1
|
Short M, Dobson J, Day G, Lefferts B, Singleton R, Keck J. "You can feel the fresh air … " Rural Alaska Native household perceptions of home air purifiers and health. Int J Circumpolar Health 2024; 83:2335702. [PMID: 38546171 PMCID: PMC10984226 DOI: 10.1080/22423982.2024.2335702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2023] [Accepted: 03/22/2024] [Indexed: 04/04/2024] Open
Abstract
Alaska Native and American Indian children experience frequent respiratory illness. Indoor air quality is associated with the severity and frequency of respiratory infections in children. High efficiency particulate air (HEPA) purifiers effectively improve indoor air quality and may protect respiratory health. In 2019, the Yukon-Kuskokwim Health Corporation implemented a pilot programme that provided education and HEPA purifiers to households of children with chronic lung conditions. The team evaluated HEPA purifier acceptability and use by interviewing representatives from 11 households that participated in the pilot programme. All interviewees reported improvement in their child's health, and some believed that the health of other household members was also improved because of the HEPA purifier. Interviewees reported that the HEPA purifiers were easy to use, quiet, and not expensive to run. Five of 11 households were still using the HEPA purifier at the time of the interview, which was about three years after receipt of the unit. The most common reasons for discontinuing use were equipment failure and lack of replacement filter, suggesting that programme support could increase sustainability. Our evaluation suggests that HEPA purifiers are acceptable and feasible for use in rural Alaska Native households.
Collapse
Affiliation(s)
- Madilyn Short
- WWAMI School of Medical Education, University of Alaska Anchorage, Anchorage, AK, USA
- Department of Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
| | - Jennifer Dobson
- Department of Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
- Office of Environmental Health and Engineering, Yukon-Kuskokwim Health Corporation, Bethel, AK, USA
| | - Gretchen Day
- Department of Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
| | - Brian Lefferts
- Office of Environmental Health and Engineering, Yukon-Kuskokwim Health Corporation, Bethel, AK, USA
| | - Rosalyn Singleton
- Department of Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
| | - James Keck
- WWAMI School of Medical Education, University of Alaska Anchorage, Anchorage, AK, USA
- Department of Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
| |
Collapse
|
2
|
Hayes AM, Schiavo L, Constantino-Casas F, Desmas I, Dobson J, Draper A, Elliot J, Genain MA, Wang J, Murchison EP. Transmission of canine transmissible venereal tumour between two dogs in the UK. J Small Anim Pract 2023; 64:590-594. [PMID: 36990106 PMCID: PMC7615759 DOI: 10.1111/jsap.13607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Revised: 09/21/2022] [Accepted: 01/24/2023] [Indexed: 03/30/2023]
Abstract
Canine transmissible venereal tumour (CTVT) is a contagious cancer spread by transfer of living cancer cells. Occasional cases are observed in the UK in dogs imported from endemic regions. Here, we report a case of imported canine transmissible venereal tumour that was transmitted to a second dog within the UK. Transmission of genital canine transmissible venereal tumour occurred despite neutered status of the second dog. The aggressive course of disease in both cases, which included metastasis, resistance to therapeutic interventions and ultimate euthanasia of both dogs, is described. The diagnosis of canine transmissible venereal tumour was made using a combination of cytology, histology, immunohistochemistry and PCR to detect the LINE-MYC rearrangement. Practitioners unfamiliar with canine transmissible venereal tumour are reminded of this disease of concern, particularly when imported dogs are placed in multi-dog households, irrespective of neuter status.
Collapse
Affiliation(s)
- A M Hayes
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - L Schiavo
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - F Constantino-Casas
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - I Desmas
- Davies Veterinary Specialists, Hitchin, SG53HR, UK
| | - J Dobson
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - A Draper
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - J Elliot
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
- Southfields Veterinary Specialists, Essex, SS15 6TP, UK
| | - M-A Genain
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - J Wang
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - E P Murchison
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| |
Collapse
|
3
|
Lutz CS, Hartman RM, Vigil DE, Britton A, Burrage AB, Campbell AP, Close RM, Desnoyers C, Dobson J, Garcia S, Halasa N, Honie E, Kobayashi M, McMorrow M, Mostafa HH, Parker D, Pohl K, Prill MM, Richards J, Roessler KC, Sutcliffe CG, Taylor K, Swango-Wilson A, Va P, Verani JR, Singleton RJ, Hammitt LL. Effectiveness of COVID-19 mRNA vaccines in preventing COVID-19-associated outpatient visits and hospitalizations among American Indian and Alaska Native persons, January–November 2021: a test-negative case-control analysis using surveillance data. Open Forum Infect Dis 2023; 10:ofad172. [PMID: 37089780 PMCID: PMC10114530 DOI: 10.1093/ofid/ofad172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Accepted: 03/23/2023] [Indexed: 03/29/2023] Open
Abstract
Abstract
Background
Despite the disproportionate morbidity and mortality experienced by American Indian and Alaska Native (AI/AN) persons during the COVID-19 pandemic, few studies have reported vaccine effectiveness (VE) estimates among these communities.
Methods
We conducted a test-negative case-control analysis among AI/AN persons aged ≥12 years presenting for care from January 1, 2021 through November 30, 2021 to evaluate effectiveness of mRNA COVID-19 vaccines against COVID-19-associated outpatient visits and hospitalizations. Cases and controls were patients with ≥1 symptom consistent with COVID-19-like illness; cases were defined as those test-positive for SARS-CoV-2 and controls were defined as those test-negative for SARS-CoV-2. We used unconditional multivariable logistic regression to estimate VE, defined as 1 minus the adjusted odds ratio for vaccination among cases versus controls.
Results
The analysis included 207 cases and 267 test-negative controls. Forty-four percent of cases and 78% of controls received two doses of either BNT162b2 or mRNA-1273 vaccine. VE point estimates for two doses of mRNA vaccine were higher for hospitalized participants (94.6% [88.0–97.6]) than outpatient participants (86.5% [63.0–95.0]), but confidence intervals overlapped.
Conclusions
Among AI/AN persons, mRNA COVID-19 vaccines were highly effective in preventing COVID-associated outpatient visits and hospitalizations. Maintaining high vaccine coverage, including booster doses, will reduce the burden of disease in this population.
Collapse
Affiliation(s)
- Chelsea S Lutz
- Correspondence: Chelsea S. Lutz, MPH, Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N. Washington St, Baltimore, MD 21231 (); or Laura L. Hammitt, MD, Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N. Washington St, Baltimore, MD 21231 ()
| | - Rachel M Hartman
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Deionna E Vigil
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Amadea Britton
- CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Amanda B Burrage
- Tuba City Service Unit, Navajo Area, Indian Health Service, Tuba City, Arizona, USA
| | - Angela P Campbell
- CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Ryan M Close
- Whiteriver Service Unit, Phoenix Area, Indian Health Service, Whiteriver, Arizona, USA
| | | | - Jennifer Dobson
- Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA
| | - Starla Garcia
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Natasha Halasa
- Vanderbilt University Medical Center, Nashville, Tennessee, USA
| | - Elvira Honie
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Miwako Kobayashi
- CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Meredith McMorrow
- CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Heba H Mostafa
- Division of Medical Microbiology, Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
| | - Dennie Parker
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Kyle Pohl
- Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA
| | - Mila M Prill
- CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Jennifer Richards
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Kristen C Roessler
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Catherine G Sutcliffe
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Kim Taylor
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | | | - Puthiery Va
- Chinle Service Unit, Navajo Area, Indian Health Service, Chinle, Arizona, USA
| | - Jennifer R Verani
- CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | | | - Laura L Hammitt
- Correspondence: Chelsea S. Lutz, MPH, Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N. Washington St, Baltimore, MD 21231 (); or Laura L. Hammitt, MD, Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N. Washington St, Baltimore, MD 21231 ()
| |
Collapse
|
4
|
Dobson J, Dockrell D, Berg K, Harris H. POS1496-HPR HARD TIMES: ADAPTING A FATIGUE MANAGEMENT PROGRAMME IN A PANDEMIC. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.57] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundFatigue is a symptom of many Rheumatology Conditions (1). Hewlett et al have shown that a Fatigue Management programme (FMP) is effective in reducing fatigue in Rheumatoid Arthritis patients (2). In 2019, a 7-week group-based FMP was developed using a cognitive behavioural approach for Rheumatology patients in NHS Lothian (Scotland). In 2020, due to COVID-19, the in person FMP was adapted for virtual delivery. Referral criteria included Visual Analogue Scale-Fatigue (VAS-F) of ≥6/10 and an inflammatory rheumatic disease diagnosis. The FMP participants recorded Patient Reported Outcome Measures (PROMs) prior to and on completion of the FMP. In August 2021 demand for the FMP far outweighed the capacity of the delivery team and therefore the original 7-week FMP was further adapted to a 4-week programme. This was achieved by focusing on four core elements (i) sleep, (ii) thoughts, emotions and behaviours, (iii) energy conservation, (iv) setbacks.ObjectivesThe primary objective was to evaluate whether the 4-week programme produced comparable PROMs results to the 7-week programme. In doing so, the aim was to maintain efficacy of the programme and provide increased capacity by offering more groups in the same timeframe.MethodsFatigue Severity Scale (FSS) and VAS-F were selected for comparison between pre and post FMP PROMs results, these being the main indicators of improvement in fatigue management. Fisher’s exact test was used to determine any difference between the PROMs results reported at the end of both programmes. Participants who reported that their PROMs result were the same, worse or who did not respond, were all placed into the category “Other”. The FMP team recorded the average waiting time for those attending each group. The length of the waiting list at any one time was calculated by removing those who were not interested, had been referred elsewhere, or who did not respond to the invitation, from the total number of referrals received by the FMP team.ResultsThere was no significant difference in FSS and VAS-F results reported by the participants in both groups at the end of the FMPs as determined by Fisher’s exact test (Table 1). Waiting list times reduced from 24 weeks in August 2021 to 6 weeks in December 2021 as a result of the adaptation of the FMP from a 7-week programme to a 4-week programme (Figure 1).Table 1.Reported differences between pre-FMP and post-FMP PROMs.7 Week FMP (n = 25)4 Week FMP (n = 13)Fischer ExactFSSImproved72%77%p = 1.000Other28%23%VASImproved80%69%p = 0.689Other20%31%Figure 1.- Review of average waiting times experienced by each group. In August 2021, the decision was made to trial a 4-week FMP to counter large increases in average waiting times.ConclusionA 4-week FMP is as effective at improving the management of fatigue in Rheumatology patients as a 7-week FMP and reduces patient waiting times. More research is required to bolster the evidence base to support this novel approach.References[1]Overman, C.L., Kool, M.B., Da Silva, J.A.P. et al. The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol35, 409–415 (2016).[2]Hewlett, S., et al., Group cognitive–behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations. Health Technology Assessment 23(57), 1-130 (2019).Disclosure of InterestsJoanne Dobson: None declared, Dervil Dockrell: None declared, Kathryn Berg: None declared, Helen Harris Speakers bureau: Galapagos
Collapse
|
5
|
Bouamra B, Chakroun K, Medeiros De Bustos E, Dobson J, Rouge JA, Moulin T. Simulation-Based Teaching of Telemedicine for Future Users of Teleconsultation and Tele-Expertise: Feasibility Study. JMIR Med Educ 2021; 7:e30440. [PMID: 34941553 PMCID: PMC8734919 DOI: 10.2196/30440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/14/2021] [Revised: 09/20/2021] [Accepted: 09/20/2021] [Indexed: 06/14/2023]
Abstract
BACKGROUND Health care professionals worldwide are increasingly using telemedicine in their daily clinical practice. However, there is still a lack of dedicated education and training even though it is needed to improve the quality of the diverse range of telemedicine activities. Simulation-based training may be a useful tool in telemedicine education and training delivery. OBJECTIVE This study aims to assess the feasibility and acceptability of simulation-based telemedicine training. METHODS We assessed five telemedicine training sessions conducted in a simulation laboratory. The training was focused on video teleconsultations between a patient and a health care professional. The assessment included the participants' satisfaction and attitudes toward the training. RESULTS We included 29 participants in total. Participant satisfaction was high (mean score 4.9 of 5), and those that took part stated the high applicability of the simulation-based training to their telemedicine practices (mean score 4.6 of 5). They also stated that they intended to use telemedicine in the future (mean score 4.5 of 5). CONCLUSIONS Simulation-based training of telemedicine dedicated to video teleconsultation was feasible and showed high satisfaction from participants. However, it remains difficult to scale for a high number of health care professionals.
Collapse
Affiliation(s)
- Benjamin Bouamra
- Department of Neurology, Besançon University Hospital, Besançon, France
| | - Karim Chakroun
- Department of Neurology, Besançon University Hospital, Besançon, France
| | | | - Jennifer Dobson
- Department of Neurology, Besançon University Hospital, Besançon, France
| | - Jeanne-Antide Rouge
- Faculty of Medicine, University of Franche-Comté MedSim Laboratory, Besançon, France
| | - Thierry Moulin
- Department of Neurology, Besançon University Hospital, Besançon, France
| |
Collapse
|
6
|
Affiliation(s)
- Thierry Moulin
- Faculty of Medicine and Health Sciences, University of Bourgogne Franche-Comté, Besançon, France
| | - Jennifer Dobson
- Faculty of Medicine and Health Sciences, University of Bourgogne Franche-Comté, Besançon, France
| | | | | |
Collapse
|
7
|
Grippin A, Wummer B, Wildes T, Dyson K, Mendez-Gomez H, Dobson J, Mitchell D, Sayour E. Versatile mRNA-Nanoparticle Platform for Treatment of Glioblastoma. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
8
|
Cunliffe A, Dobson J, Swallow G, Ravenscroft J, Tang TS. Taipan snake venom time for antiphospholipid syndrome solves a 20-year diagnostic challenge. Clin Exp Dermatol 2020; 45:805-808. [PMID: 32432361 DOI: 10.1111/ced.14229] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/17/2020] [Indexed: 01/06/2023]
Affiliation(s)
- A Cunliffe
- Department of Dermatology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - J Dobson
- Department of Dermatology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - G Swallow
- Department of, Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - J Ravenscroft
- Department of Dermatology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - T S Tang
- Department of Dermatology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| |
Collapse
|
9
|
Giuliano A, Watson P, Owen L, Skelly B, Davison L, Dobson J, Costantino‐Casas F. Idiopathic sterile pyogranuloma in three domestic cats. J Small Anim Pract 2020; 61:202-205. [PMID: 29761888 PMCID: PMC7166439 DOI: 10.1111/jsap.12853] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2017] [Revised: 01/29/2018] [Accepted: 03/02/2018] [Indexed: 11/25/2022]
Abstract
Pyogranulomatous inflammation has been extensively described in cats, in particular in cases of feline infectious peritonitis and also associated with Mycobacteria, Actinomyces, Nocardia, Rhodococcus and fungal infections. Idiopathic sterile pyogranulomatous dermatitis has also been described. In this case series we describe the clinical presentation, histopathology and outcome of three cases of feline idiopathic sterile steroid-responsive pyogranuloma with different presentation and different locations of the lesion, but with the common feature of having a mass with no superficial skin involvement.
Collapse
Affiliation(s)
- A. Giuliano
- Department of Veterinary MedicineUniversity of CambridgeCambridge, CB3 0ESUK
| | - P. Watson
- Department of Veterinary MedicineUniversity of CambridgeCambridge, CB3 0ESUK
| | - L. Owen
- Department of Veterinary MedicineUniversity of CambridgeCambridge, CB3 0ESUK
| | - B. Skelly
- Department of Veterinary MedicineUniversity of CambridgeCambridge, CB3 0ESUK
| | - L. Davison
- Department of Veterinary MedicineUniversity of CambridgeCambridge, CB3 0ESUK
| | - J. Dobson
- Department of Veterinary MedicineUniversity of CambridgeCambridge, CB3 0ESUK
| | - F. Costantino‐Casas
- Department of Veterinary MedicineUniversity of CambridgeCambridge, CB3 0ESUK
| |
Collapse
|
10
|
Mosites E, Lefferts B, Seeman S, January G, Dobson J, Fuente D, Bruce M, Thomas T, Hennessy T. Community water service and incidence of respiratory, skin, and gastrointestinal infections in rural Alaska, 2013-2015. Int J Hyg Environ Health 2020; 225:113475. [PMID: 32058938 DOI: 10.1016/j.ijheh.2020.113475] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2019] [Revised: 01/22/2020] [Accepted: 01/29/2020] [Indexed: 10/25/2022]
Abstract
BACKGROUND Communities in rural Alaska have access to multiple types of water service (piped, vehicle-hauled, and self-hauled) and experience varying levels of water service coverage. We assessed the incidence rate of inpatient and outpatient infectious disease visits among communities with different water service types and coverage levels. METHODS We classified ICD-9 codes for inpatient and outpatient visits to the Yukon-Kuskokwim Health Corporation facilities between 2013 and 2015 into six infectious disease categories. Using Poisson models, we compared the incidence of visits in each category across communities with differing water service coverage levels as defined by water service billing data for the same years. Using census data, we adjusted for community median household income, median age, crowding, and health aide staffing. RESULTS We included 48 communities in this analysis. After adjusting for possible confounders, each 10% increase in piped water coverage was associated with a 4% lower incidence of pneumonia/influenza visits (adjusted incidence rate ratio [IRR] 0.96, 95% CI 0.93-0.98), a 2% lower incidence of other respiratory infection visits (adjusted IRR 0.98, 95% CI 0.97-0.99), an 8% lower incidence of methicillin-resistant Staphylococcus visits (adjusted IRR 0.92, 95% CI 0.87-0.97), and a 4% lower incidence of other skin infections visits (adjusted IRR 0.96, 95% CI 0.95-0.98). Each 10% increase in vehicle-hauled water coverage was associated with a 2% lower incidence of respiratory infection visits (adjusted IRR 0.98, 95% CI 0.97-0.996) and a 3% lower incidence of skin infection visits (adjusted IRR 0.97, 95% CI 0.95-0.99), also after adjustment. CONCLUSIONS Higher levels of water service coverage were associated with lower incidence rates of visits for several infectious disease categories. These associations were more pronounced for communities with piped water service compared to vehicle-hauled water service.
Collapse
Affiliation(s)
- Emily Mosites
- Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Zoonotic and Emerging Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA.
| | - Brian Lefferts
- Office of Environmental Health and Engineering, Yukon-Kuskokwim Health Corporation, Bethel, AK, USA
| | - Sara Seeman
- Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Zoonotic and Emerging Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA
| | - Gerald January
- Records and Verification Electronic Network (RAVEN) Team, Yukon-Kuskokwim Health Corporation, Bethel, AK, USA
| | - Jennifer Dobson
- Office of Environmental Health and Engineering, Yukon-Kuskokwim Health Corporation, Bethel, AK, USA
| | - David Fuente
- School of Earth, Ocean, and Environment, College of Arts and Sciences, University of South Carolina, Columbia, SC, USA
| | - Michael Bruce
- Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Zoonotic and Emerging Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA
| | - Timothy Thomas
- Clinical Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
| | - Thomas Hennessy
- Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Zoonotic and Emerging Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA
| |
Collapse
|
11
|
Giuliano A, Dobson J. Prospective clinical trial of masitinib mesylate treatment for advanced stage III and IV canine malignant melanoma. J Small Anim Pract 2020; 61:190-194. [PMID: 31960455 DOI: 10.1111/jsap.13111] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2019] [Revised: 10/31/2019] [Accepted: 12/04/2019] [Indexed: 01/07/2023]
Abstract
OBJECTIVE To investigate efficacy of masitinib mesylate for the treatment of advanced malignant melanoma in dogs. MATERIALS AND METHODS Prospective clinical trial on 17 dogs with stage III and IV malignant melanoma (two digital, one anal and 14 oral mucosal). Only dogs with advanced gross disease for which the owner declined conventional treatment or dogs with progressive tumour despite conventional treatment were included. RESULTS There was a partial response in two dogs, stable disease in seven and tumour progression in eight dogs. Median survival time for all 17 dogs was 119 days (range 21-255). Masitinib was generally well-tolerated but grade 2 anaemia, grade 1 neutropenia, grade 1 diarrhoea and grade 2 anorexia were observed in one dog each. CLINICAL SIGNIFICANCE There was only mild effectiveness in end-stage disease, indicating that masitinib mesylate is not an appropriate sole-agent option for treatment of advanced malignant melanoma in dogs.
Collapse
Affiliation(s)
- A Giuliano
- *Department of Veterinary Medicine, University of Cambridge, Cambridge, CB30 ES, UK
| | - J Dobson
- *Department of Veterinary Medicine, University of Cambridge, Cambridge, CB30 ES, UK
| |
Collapse
|
12
|
Pittaway C, Schofield I, Dobson J, O'Neill DG, Brodbelt DC. Incidence and risk factors for the diagnosis of lymphoma in dogs in UK primary-care practice. J Small Anim Pract 2019; 60:581-588. [PMID: 31328276 DOI: 10.1111/jsap.13054] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2018] [Revised: 04/19/2019] [Accepted: 04/26/2019] [Indexed: 02/03/2023]
Abstract
OBJECTIVES To identify the incidence, risk factors and presenting signs of lymphoma in dogs presenting to primary-care practice in the UK using analysis of data within the VetCompass™ programme. MATERIALS AND METHODS Case records from the VetCompass™ programme from primary-care practices in the UK were searched for newly diagnosed lymphoma in dogs within a 1-year period: 2013. Diagnosis was based on clinical records with or without laboratory confirmation. Signalment was evaluated as risk factors for lymphoma diagnosis using multivariable logistic regression. RESULTS There were 286 presumed newly diagnosed cases identified during 2013 from 455,553 dogs (overall incidence risk 63 of 100,000 dogs per year) of which 193 (67%) were laboratory confirmed (42 of 100,000 dogs per year). Advanced age, dogs older than 12 years, dogs weighing more than 30 kg and some specific breeds were significantly associated with lymphoma diagnosis. Only 18 dogs (6%) of the population identified were referred to a specialist clinic. CLINICAL SIGNIFICANCE This study concurs with others that age, bodyweight and breed are significant risk factors for lymphoma. Results of this study highlight: (1) the low number of dogs with lymphoma that are referred to specialists in the UK and (2) that few dogs undergo immunophenotyping (which can carry prognostic importance), emphasising the importance of epidemiological programmes that evaluate diseases presented to primary-care veterinarians.
Collapse
Affiliation(s)
- C Pittaway
- The Queen's Veterinary School Hospital, Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - I Schofield
- Pathobiology and Population Sciences, The Royal Veterinary College, Hatfield, Herts, AL9 7TA, UK
| | - J Dobson
- The Queen's Veterinary School Hospital, Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - D G O'Neill
- Pathobiology and Population Sciences, The Royal Veterinary College, Hatfield, Herts, AL9 7TA, UK
| | - D C Brodbelt
- Pathobiology and Population Sciences, The Royal Veterinary College, Hatfield, Herts, AL9 7TA, UK
| |
Collapse
|
13
|
Millington GWM, Dobson J, Holden S, Waters G, Puvanachandra N, Close R, Bale P, Armon K. Sporadic Blau syndrome treated with adalimumab. Clin Exp Dermatol 2019; 44:811-813. [DOI: 10.1111/ced.14016] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/09/2019] [Indexed: 11/26/2022]
Affiliation(s)
- G. W. M. Millington
- Department of Dermatology Norfolk and Norwich University Hospital Norwich UK
| | - J. Dobson
- Department of Dermatology Norfolk and Norwich University Hospital Norwich UK
| | - S. Holden
- Department of Clinical GeneticsCambridge University Hospitals CambridgeUK
| | - G. Waters
- Department of Cellular PathologyNorfolk and Norwich University Hospital NorwichUK
| | - N. Puvanachandra
- Department of Ophthalmology Norfolk and Norwich University Hospital Norwich UK
| | - R. Close
- Department of Paediatric Rheumatology Cambridge University Hospitals Cambridge UK
| | - P. Bale
- Department of Paediatric Rheumatology Cambridge University Hospitals Cambridge UK
| | - K. Armon
- Department of Paediatric Rheumatology Cambridge University Hospitals Cambridge UK
| |
Collapse
|
14
|
McLean K, Glasbey J, Borakati A, Brooks T, Chang H, Choi S, Goodson R, Nielsen M, Pronin S, Salloum N, Sewart E, Vanniasegaram D, Drake T, Gillies M, Harrison E, Chapman S, Khatri C, Kong C, Claireaux H, Bath M, Mohan M, McNamee L, Kelly M, Mitchell H, Fitzgerald J, Bhangu A, Nepogodiev D, Antoniou I, Dean R, Davies N, Trecarten S, Henderson I, Holmes C, Wylie J, Shuttleworth R, Jindal A, Hughes F, Gouda P, Fleck R, Hanrahan M, Karunakaran P, Chen J, Sykes M, Sethi R, Suresh S, Patel P, Patel M, Varma R, Mushtaq J, Gundogan B, Bolton W, Khan T, Burke J, Morley R, Favero N, Adams R, Thirumal V, Kennedy E, Ong K, Tan Y, Gabriel J, Bakhsh A, Low J, Yener A, Paraoan V, Preece R, Tilston T, Cumber E, Dean S, Ross T, McCance E, Amin H, Satterthwaite L, Clement K, Gratton R, Mills E, Chiu S, Hung G, Rafiq N, Hayes J, Robertson K, Dynes K, Huang H, Assadullah S, Duncumb J, Moon R, Poo S, Mehta J, Joshi K, Callan R, Norris J, Chilvers N, Keevil H, Jull P, Mallick S, Elf D, Carr L, Player C, Barton E, Martin A, Ratu S, Roberts E, Phan P, Dyal A, Rogers J, Henson A, Reid N, Burke D, Culleton G, Lynne S, Mansoor S, Brennan C, Blessed R, Holloway C, Hill A, Goldsmith T, Mackin S, Kim S, Woin E, Brent G, Coffin J, Ziff O, Momoh Z, Debenham R, Ahmed M, Yong C, Wan J, Copley H, Raut P, Chaudhry F, Nixon G, Dorman C, Tan R, Kanabar S, Canning N, Dolaghan M, Bell N, McMenamin M, Chhabra A, Duke K, Turner L, Patel T, Chew L, Mirza M, Lunawat S, Oremule B, Ward N, Khan M, Tan E, Maclennan D, McGregor R, Chisholm E, Griffin E, Bell L, Hughes B, Davies J, Haq H, Ahmed H, Ungcharoen N, Whacha C, Thethi R, Markham R, Lee A, Batt E, Bullock N, Francescon C, Davies J, Shafiq N, Zhao J, Vivekanantham S, Barai I, Allen J, Marshall D, McIntyre C, Wilson H, Ashton A, Lek C, Behar N, Davis-Hall M, Seneviratne N, Esteve L, Sirakaya M, Ali S, Pope S, Ahn J, Craig-McQuaide A, Gatfield W, Leong S, Demetri A, Kerr A, Rees C, Loveday J, Liu S, Wijesekera M, Maru D, Attalla M, Smith N, Brown D, Sritharan P, Shah A, Charavanamuttu V, Heppenstall-Harris G, Ng K, Raghvani T, Rajan N, Hulley K, Moody N, Williams M, Cotton A, Sharifpour M, Lwin K, Bright M, Chitnis A, Abdelhadi M, Semana A, Morgan F, Reid R, Dickson J, Anderson L, McMullan R, Ahern N, Asmadi A, Anderson L, Boon Xuan JL, Crozier L, McAleer S, Lees D, Adebayo A, Das M, Amphlett A, Al-Robeye A, Valli A, Khangura J, Winarski A, Ali A, Woodward H, Gouldthrope C, Turner M, Sasapu K, Tonkins M, Wild J, Robinson M, Hardie J, Heminway R, Narramore R, Ramjeeawon N, Hibberd A, Winslow F, Ho W, Chong B, Lim K, Ho S, Crewdson J, Singagireson S, Kalra N, Koumpa F, Jhala H, Soon W, Karia M, Rasiah M, Xylas D, Gilbert H, Sundar-Singh M, Wills J, Akhtar S, Patel S, Hu L, Brathwaite-Shirley C, Nayee H, Amin O, Rangan T, Turner E, McCrann C, Shepherd R, Patel N, Prest-Smith J, Auyoung E, Murtaza A, Coates A, Prys-Jones O, King M, Gaffney S, Dewdney C, Nehikhare I, Lavery J, Bassett J, Davies K, Ahmad K, Collins A, Acres M, Egerton C, Cheng K, Chen X, Chan N, Sheldon A, Khan S, Empey J, Ingram E, Malik A, Johnstone M, Goodier R, Shah J, Giles J, Sanders J, McLure S, Pal S, Rangedara A, Baker A, Asbjoernsen C, Girling C, Gray L, Gauntlett L, Joyner C, Qureshi S, Mogan Y, Ng J, Kumar A, Park J, Tan D, Choo K, Raman K, Buakuma P, Xiao C, Govinden S, Thompson O, Charalambos M, Brown E, Karsan R, Dogra T, Bullman L, Dawson P, Frank A, Abid H, Tung L, Qureshi U, Tahmina A, Matthews B, Harris R, O'Connor A, Mazan K, Iqbal S, Stanger S, Thompson J, Sullivan J, Uppal E, MacAskill A, Bamgbose F, Neophytou C, Carroll A, Rookes C, Datta U, Dhutia A, Rashid S, Ahmed N, Lo T, Bhanderi S, Blore C, Ahmed S, Shaheen H, Abburu S, Majid S, Abbas Z, Talukdar S, Burney L, Patel J, Al-Obaedi O, Roberts A, Mahboob S, Singh B, Sheth S, Karia P, Prabhudesai A, Kow K, Koysombat K, Wang S, Morrison P, Maheswaran Y, Keane P, Copley P, Brewster O, Xu G, Harries P, Wall C, Al-Mousawi A, Bonsu S, Cunha P, Ward T, Paul J, Nadanakumaran K, Tayeh S, Holyoak H, Remedios J, Theodoropoulou K, Luhishi A, Jacob L, Long F, Atayi A, Sarwar S, Parker O, Harvey J, Ross H, Rampal R, Thomas G, Vanmali P, McGowan C, Stein J, Robertson V, Carthew L, Teng V, Fong J, Street A, Thakker C, O'Reilly D, Bravo M, Pizzolato A, Khokhar H, Ryan M, Cheskes L, Carr R, Salih A, Bassiony S, Yuen R, Chrastek D, Rosen O'Sullivan H, Amajuoyi A, Wang A, Sitta O, Wye J, Qamar M, Major C, Kaushal A, Morgan C, Petrarca M, Allot R, Verma K, Dutt S, Chilima C, Peroos S, Kosasih S, Chin H, Ashken L, Pearse R, O'Loughlin R, Menon A, Singh K, Norton J, Sagar R, Jathanna N, Rothwell L, Watson N, Harding F, Dube P, Khalid H, Punjabi N, Sagmeister M, Gill P, Shahid S, Hudson-Phillips S, George D, Ashwood J, Lewis T, Dhar M, Sangal P, Rhema I, Kotecha D, Afzal Z, Syeed J, Prakash E, Jalota P, Herron J, Kimani L, Delport A, Shukla A, Agarwal V, Parthiban S, Thakur H, Cymes W, Rinkoff S, Turnbull J, Hayat M, Darr S, Khan U, Lim J, Higgins A, Lakshmipathy G, Forte B, Canning E, Jaitley A, Lamont J, Toner E, Ghaffar A, McDowell M, Salmon D, O'Carroll O, Khan A, Kelly M, Clesham K, Palmer C, Lyons R, Bell A, Chin R, Waldron R, Trimble A, Cox S, Ashfaq U, Campbell J, Holliday R, McCabe G, Morris F, Priestland R, Vernon O, Ledsam A, Vaughan R, Lim D, Bakewell Z, Hughes R, Koshy R, Jackson H, Narayan P, Cardwell A, Jubainville C, Arif T, Elliott L, Gupta V, Bhaskaran G, Odeleye A, Ahmed F, Shah R, Pickard J, Suleman Y, North A, McClymont L, Hussain N, Ibrahim I, Ng G, Wong V, Lim A, Harris L, Tharmachandirar T, Mittapalli D, Patel V, Lakhani M, Bazeer H, Narwani V, Sandhu K, Wingfield L, Gentry S, Adjei H, Bhatti M, Braganza L, Barnes J, Mistry S, Chillarge G, Stokes S, Cleere J, Wadanamby S, Bucko A, Meek J, Boxall N, Heywood E, Wiltshire J, Toh C, Ward A, Shurovi B, Horth D, Patel B, Ali B, Spencer T, Axelson T, Kretzmer L, Chhina C, Anandarajah C, Fautz T, Horst C, Thevathasan A, Ng J, Hirst F, Brewer C, Logan A, Lockey J, Forrest P, Keelty N, Wood A, Springford L, Avery P, Schulz T, Bemand T, Howells L, Collier H, Khajuria A, Tharakan R, Parsons S, Buchan A, McGalliard R, Mason J, Cundy O, Li N, Redgrave N, Watson R, Pezas T, Dennis Y, Segall E, Hameed M, Lynch A, Chamberlain M, Peck F, Neo Y, Russell G, Elseedawy M, Lee S, Foster N, Soo Y, Puan L, Dennis R, Goradia H, Qureshi A, Osman S, Reeves T, Dinsmore L, Marsden M, Lu Q, Pitts-Tucker T, Dunn C, Walford R, Heathcote E, Martin R, Pericleous A, Brzyska K, Reid K, Williams M, Wetherall N, McAleer E, Thomas D, Kiff R, Milne S, Holmes M, Bartlett J, Lucas de Carvalho J, Bloomfield T, Tongo F, Bremner R, Yong N, Atraszkiewicz B, Mehdi A, Tahir M, Sherliker G, Tear A, Pandey A, Broyd A, Omer H, Raphael M, Chaudhry W, Shahidi S, Jawad A, Gill C, Fisher IH, Adeleja I, Clark I, Aidoo-Micah G, Stather P, Salam G, Glover T, Deas G, Sim N, Obute R, Wynell-Mayow W, Sait M, Mitha N, de Bernier G, Siddiqui M, Shaunak R, Wali A, Cuthbert G, Bhudia R, Webb E, Shah S, Ansari N, Perera M, Kelly N, McAllister R, Stanley G, Keane C, Shatkar V, Maxwell-Armstrong C, Henderson L, Maple N, Manson R, Adams R, Semple E, Mills M, Daoub A, Marsh A, Ramnarine A, Hartley J, Malaj M, Jewell P, Whatling E, Hitchen N, Chen M, Goh B, Fern J, Rogers S, Derbyshire L, Robertson D, Abuhussein N, Deekonda P, Abid A, Harrison P, Aildasani L, Turley H, Sherif M, Pandey G, Filby J, Johnston A, Burke E, Mohamud M, Gohil K, Tsui A, Singh R, Lim S, O'Sullivan K, McKelvey L, O'Neill S, Roberts H, Brown F, Cao Y, Buckle R, Liew Y, Sii S, Ventre C, Graham C, Filipescu T, Yousif A, Dawar R, Wright A, Peters M, Varley R, Owczarek S, Hartley S, Khattak M, Iqbal A, Ali M, Durrani B, Narang Y, Bethell G, Horne L, Pinto R, Nicholls K, Kisyov I, Torrance H, English W, Lakhani S, Ashraf S, Venn M, Elangovan V, Kazmi Z, Brecher J, Sukumar S, Mastan A, Mortimer A, Parker J, Boyle J, Elkawafi M, Beckett J, Mohite A, Narain A, Mazumdar E, Sreh A, Hague A, Weinberg D, Fletcher L, Steel M, Shufflebotham H, Masood M, Sinha Y, Jenvey C, Kitt H, Slade R, Craig A, Deall C, Reakes T, Chervenkoff J, Strange E, O'Bryan M, Murkin C, Joshi D, Bergara T, Naqib S, Wylam D, Scotcher S, Hewitt C, Stoddart M, Kerai A, Trist A, Cole S, Knight C, Stevens S, Cooper G, Ingham R, Dobson J, O'Kane A, Moradzadeh J, Duffy A, Henderson C, Ashraf S, McLaughin C, Hoskins T, Reehal R, Bookless L, McLean R, Stone E, Wright E, Abdikadir H, Roberts C, Spence O, Srikantharajah M, Ruiz E, Matthews J, Gardner E, Hester E, Naran P, Simpson R, Minhas M, Cornish E, Semnani S, Rojoa D, Radotra A, Eraifej J, Eparh K, Smith D, Mistry B, Hickling S, Din W, Liu C, Mithrakumar P, Mirdavoudi V, Rashid M, Mcgenity C, Hussain O, Kadicheeni M, Gardner H, Anim-Addo N, Pearce J, Aslanyan A, Ntala C, Sorah T, Parkin J, Alizadeh M, White A, Edozie F, Johnston J, Kahar A, Navayogaarajah V, Patel B, Carter D, Khonsari P, Burgess A, Kong C, Ponweera A, Cody A, Tan Y, Ng A, Croall A, Allan C, Ng S, Raghuvir V, Telfer R, Greenhalgh A, McKerr C, Edison M, Patel B, Dear K, Hardy M, Williams P, Hassan S, Sajjad U, O'Neill E, Lopes S, Healy L, Jamal N, Tan S, Lazenby D, Husnoo S, Beecroft S, Sarvanandan T, Weston C, Bassam N, Rabinthiran S, Hayat U, Ng L, Varma D, Sukkari M, Mian A, Omar A, Kim J, Sellathurai J, Mahmood J, O'Connell C, Bose R, Heneghan H, Lalor P, Matheson J, Doherty C, Cullen C, Cooper D, Angelov S, Drislane C, Smith A, Kreibich A, Palkhi E, Durr A, Lotfallah A, Gold D, Mckean E, Dhanji A, Anilkumar A, Thacoor A, Siddiqui Z, Lim S, Piquet A, Anderson S, McCormack D, Gulati J, Ibrahim A, Murray S, Walsh S, McGrath A, Ziprin P, Chua E, Lou C, Bloomer J, Paine H, Osei-Kuffour D, White C, Szczap A, Gokani S, Patel K, Malys M, Reed A, Torlot G, Cumber E, Charania A, Ahmad S, Varma N, Cheema H, Austreng L, Petra H, Chaudhary M, Zegeye M, Cheung F, Coffey D, Heer R, Singh S, Seager E, Cumming S, Suresh R, Verma S, Ptacek I, Gwozdz A, Yang T, Khetarpal A, Shumon S, Fung T, Leung W, Kwang P, Chew L, Loke W, Curran A, Chan C, McGarrigle C, Mohan K, Cullen S, Wong E, Toale C, Collins D, Keane N, Traynor B, Shanahan D, Yan A, Jafree D, Topham C, Mitrasinovic S, Omara S, Bingham G, Lykoudis P, Miranda B, Whitehurst K, Kumaran G, Devabalan Y, Aziz H, Shoa M, Dindyal S, Yates J, Bernstein I, Rattan G, Coulson R, Stezaker S, Isaac A, Salem M, McBride A, McFarlane H, Yow L, MacDonald J, Bartlett R, Turaga S, White U, Liew W, Yim N, Ang A, Simpson A, McAuley D, Craig E, Murphy L, Shepherd P, Kee J, Abdulmajid A, Chung A, Warwick H, Livesey A, Holton P, Theodoreson M, Jenkin S, Turner J, Entwisle J, Marchal S, O'Connor S, Blege H, Aithie J, Sabine L, Stewart G, Jackson S, Kishore A, Lankage C, Acquaah F, Joyce H, McKevitt K, Coffey C, Fawaz A, Dolbec K, O'Sullivan D, Geraghty J, Lim E, Bolton L, FitzPatrick D, Robinson C, Ramtoola T, Collinson S, Grundy L, McEnhill P, Harbhajan Singh G, Loughran D, Golding D, Keeling R, Williams R, Whitham R, Yoganathan S, Nachiappan R, Egan R, Owasil R, Kwan M, He A, Goh R, Bhome R, Wilson H, Teoh P, Raji K, Jayakody N, Matthams J, Chong J, Luk C, Greig R, Trail M, Charalambous G, Rocke A, Gardiner N, Bulley F, Warren N, Brennan E, Fergurson P, Wilson R, Whittingham H, Brown E, Khanijau R, Gandhi K, Morris S, Boulton A, Chandan N, Barthorpe A, Maamari R, Sandhu S, McCann M, Higgs L, Balian V, Reeder C, Diaper C, Sale T, Ali H, Archer C, Clarke A, Heskin J, Hurst P, Farmer J, O'Flynn L, Doan L, Shuker B, Stott G, Vithanage N, Hoban K, Nesargikar P, Kennedy H, Grossart C, Tan E, Roy C, Sim P, Leslie K, Sim D, Abul M, Cody N, Tay A, Woon E, Sng S, Mah J, Robson J, Shakweh E, Wing V, Mills H, Li M, Barrow T, Balaji S, Jordan H, Phillips C, Naveed H, Hirani S, Tai A, Ratnakumaran R, Sahathevan A, Shafi A, Seedat M, Weaver R, Batho A, Punj R, Selvachandran H, Bhatt N, Botchey S, Khonat Z, Brennan K, Morrison C, Devlin E, Linton A, Galloway E, McGarvie S, Ramsay N, McRobbie H, Whewell H, Dean W, Nelaj S, Eragat M, Mishra A, Kane T, Zuhair M, Wells M, Wilkinson D, Woodcock N, Sun E, Aziz N, Ghaffar MKA. Critical care usage after major gastrointestinal and liver surgery: a prospective, multicentre observational study. Br J Anaesth 2019; 122:42-50. [PMID: 30579405 DOI: 10.1016/j.bja.2018.07.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2018] [Revised: 07/19/2018] [Accepted: 07/23/2018] [Indexed: 11/23/2022] Open
Abstract
BACKGROUND Patient selection for critical care admission must balance patient safety with optimal resource allocation. This study aimed to determine the relationship between critical care admission, and postoperative mortality after abdominal surgery. METHODS This prespecified secondary analysis of a multicentre, prospective, observational study included consecutive patients enrolled in the DISCOVER study from UK and Republic of Ireland undergoing major gastrointestinal and liver surgery between October and December 2014. The primary outcome was 30-day mortality. Multivariate logistic regression was used to explore associations between critical care admission (planned and unplanned) and mortality, and inter-centre variation in critical care admission after emergency laparotomy. RESULTS Of 4529 patients included, 37.8% (n=1713) underwent planned critical care admissions from theatre. Some 3.1% (n=86/2816) admitted to ward-level care subsequently underwent unplanned critical care admission. Overall 30-day mortality was 2.9% (n=133/4519), and the risk-adjusted association between 30-day mortality and critical care admission was higher in unplanned [odds ratio (OR): 8.65, 95% confidence interval (CI): 3.51-19.97) than planned admissions (OR: 2.32, 95% CI: 1.43-3.85). Some 26.7% of patients (n=1210/4529) underwent emergency laparotomies. After adjustment, 49.3% (95% CI: 46.8-51.9%, P<0.001) were predicted to have planned critical care admissions, with 7% (n=10/145) of centres outside the 95% CI. CONCLUSIONS After risk adjustment, no 30-day survival benefit was identified for either planned or unplanned postoperative admissions to critical care within this cohort. This likely represents appropriate admission of the highest-risk patients. Planned admissions in selected, intermediate-risk patients may present a strategy to mitigate the risk of unplanned admission. Substantial inter-centre variation exists in planned critical care admissions after emergency laparotomies.
Collapse
|
15
|
Singleton R, Salkoski AJ, Bulkow L, Fish C, Dobson J, Albertson L, Skarada J, Ritter T, Kovesi T, Hennessy TW. Impact of home remediation and household education on indoor air quality, respiratory visits and symptoms in Alaska Native children. Int J Circumpolar Health 2018; 77:1422669. [PMID: 29393004 PMCID: PMC5804775 DOI: 10.1080/22423982.2017.1422669] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2017] [Accepted: 12/22/2017] [Indexed: 11/12/2022] Open
Abstract
Alaska Native children experience high rates of lower respiratory tract infections (LRTIs) and lung conditions, which are associated with substandard indoor air quality (IAQ). We conducted an intervention of home remediation and education to assess the impact on IAQ, respiratory symptoms and LRTI visits. We enrolled households of children 1-12 years of age with lung conditions. Home remediation included improving ventilation and replacing leaky woodstoves. We provided education about IAQ and respiratory health. We monitored indoor airborne particles (PM2.5), CO2, relative humidity and volatile organic compounds (VOCs), and interviewed caregivers about children's symptoms before, and for 1 year after intervention. We evaluated the association between children's respiratory visits, symptoms and IAQ indicators using multiple logistic regression. A total of 60 of 63 homes completed the study. VOCs decreased (coefficient = -0.20; p < 0.001); however, PM2.5 (coeff. = -0.010; p = 0.89) did not decrease. Burning wood for heat, VOCs and PM2.5 were associated with respiratory symptoms. After remediation, parents reported decreases in runny nose, cough between colds, wet cough, wheezing with colds, wheezing between colds and school absences. Children had an age-adjusted decrease in LRTI visits (coefficient = -0.33; p = 0.028). Home remediation and education reduced respiratory symptoms, LRTI visits and school absenteeism in children with lung conditions.
Collapse
Affiliation(s)
- Rosalyn Singleton
- Division of Community Health Services, Alaska Native Tribal Health Consortium (ANTHC), Anchorage, AK, USA
- Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (AIP-CDC), Anchorage, AK, USA
| | | | | | - Chris Fish
- Division of Environmental Health and Engineering, ANTHC, Anchorage, AK, USA
| | - Jennifer Dobson
- Office of Environmental Health, Yukon Kuskokwim Health Corporation, Bethel, AK, USA
| | - Leif Albertson
- School of Natural Resources and Extension, University of Alaska, Fairbanks, Bethel, AK, USA
| | | | - Troy Ritter
- Division of Environmental Health and Engineering, ANTHC, Anchorage, AK, USA
| | - Thomas Kovesi
- Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada
| | | |
Collapse
|
16
|
Reed H, Leckey CAC, Dick A, Harvey G, Dobson J. A model based bayesian solution for characterization of complex damage scenarios in aerospace composite structures. Ultrasonics 2018; 82:272-288. [PMID: 28934616 PMCID: PMC7437518 DOI: 10.1016/j.ultras.2017.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2017] [Revised: 09/01/2017] [Accepted: 09/01/2017] [Indexed: 06/07/2023]
Abstract
Ultrasonic damage detection and characterization is commonly used in nondestructive evaluation (NDE) of aerospace composite components. In recent years there has been an increased development of guided wave based methods. In real materials and structures, these dispersive waves result in complicated behavior in the presence of complex damage scenarios. Model-based characterization methods utilize accurate three dimensional finite element models (FEMs) of guided wave interaction with realistic damage scenarios to aid in defect identification and classification. This work describes an inverse solution for realistic composite damage characterization by comparing the wavenumber-frequency spectra of experimental and simulated ultrasonic inspections. The composite laminate material properties are first verified through a Bayesian solution (Markov chain Monte Carlo), enabling uncertainty quantification surrounding the characterization. A study is undertaken to assess the efficacy of the proposed damage model and comparative metrics between the experimental and simulated output. The FEM is then parameterized with a damage model capable of describing the typical complex damage created by impact events in composites. The damage is characterized through a transdimensional Markov chain Monte Carlo solution, enabling a flexible damage model capable of adapting to the complex damage geometry investigated here. The posterior probability distributions of the individual delamination petals as well as the overall envelope of the damage site are determined.
Collapse
Affiliation(s)
- H Reed
- Thornton Tomasetti - Weidlinger Applied Science, 40 Wall St. 19th Fl., New York, NY 10005, United States.
| | - Cara A C Leckey
- NASA Langley Research Center, Hampton, VA 23681, United States
| | - A Dick
- Thornton Tomasetti - Weidlinger Applied Science, 40 Wall St. 19th Fl., New York, NY 10005, United States
| | - G Harvey
- PZFlex, 19200 Stevens Creek Blvd, Suite 100, Cupertino, CA 95014, United States
| | - J Dobson
- PZFlex, 6th Floor South Suite, 39 St Vincent Place, Glasgow, United Kingdom; Centre for Ultrasonic Engineering, University of Strathclyde, Glasgow, United Kingdom
| |
Collapse
|
17
|
Abstract
BACKGROUND Participation in research is associated with benefits and burdens for individual research participants. Children living with a chronic illness are considered particularly vulnerable as they are already burdened with symptoms of their illness. In particular contexts, such as learning health care systems (LHS), where research and clinical care are integrated, children with chronic illnesses may be asked to participate in research related to their illness. A growing body of literature has focused on children's perspectives as research subjects; however, a relatively understudied aspect concerns children's experiences of research in clinics where they are also patients. METHODS We interviewed 25 Canadian children and adolescents living with inflammatory bowel disease (IBD) about their experiences of research participation. RESULTS Our participants described aspects of the research process and particular experiences as benefits and others as burdens. Benefits included helping others, receiving incentives, receiving the results of previous studies, and participating in fun activities. Burdens included the time required for particular types of research, physical and psychological discomfort, and feelings of obligation. CONCLUSIONS Our study describes the experiences of children participating in research at a site that integrates research and clinical care. Our participants described experiences that often go unreported (such as feelings of obligation); we mention these as important considerations to be mindful of when interacting with children as (potential) research participants in an LHS and when thinking about research ethics protocols or the assent/consent process.
Collapse
Affiliation(s)
| | | | - Alain Stintzi
- b Ottawa Institute of Systems Biology and Department of Biochemistry, Microbiology and Immunology, University of Ottawa
| | - David Mack
- c Children's Hospital of Eastern Ontario (CHEO) Inflammatory Bowel Disease Centre and CHEO Research Institute
- d Department of Pediatrics , University of Ottawa
| | | |
Collapse
|
18
|
Yarmola EG, Shah YY, Kloefkorn HE, Dobson J, Allen KD. Comparing intra-articular CTXII levels assessed via magnetic capture or lavage in a rat knee osteoarthritis model. Osteoarthritis Cartilage 2017; 25:1189-1194. [PMID: 28137664 PMCID: PMC5466845 DOI: 10.1016/j.joca.2017.01.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/27/2016] [Revised: 01/10/2017] [Accepted: 01/19/2017] [Indexed: 02/02/2023]
Abstract
OBJECTIVE Parallel measures of osteoarthritis (OA) across species can help evaluate OA models relative to humans. Toward this need, our group recently developed a magnetic nanoparticle-based technology, termed magnetic capture, to analyze biomarkers within a rat knee. The objectives of this study were to directly compare magnetic capture to lavage, and assess c-telopeptide of collagen type II (CTXII) in the rat medial meniscus transection (MMT) model of knee OA. DESIGN MMT surgery was performed in 30 male Lewis rats (3 months, 250 g). Using lavage or magnetic capture, CTXII was assessed in the OA-affected and contralateral knee at 1 week (n = 6 per group) or 4 weeks (n = 8 per group) after surgery. RESULTS While lavage detected elevated CTXII concentrations in the OA-affected knee at 1 week (P = 0.002), magnetic capture detected elevated CTXII levels in the OA-affected knee at 4 weeks (P = 0.016). While magnetic capture did not detect significant elevation of CTXII at week 1, five of six rats evaluated with magnetic capture had higher CTXII levels in the OA-affected joint relative to the contralateral limb. Moreover, with magnetic capture, CTXII levels increased from 1 week to 4 weeks, corresponding to histological damage. CTXII concentrations evaluated via lavage were relatively constant across time. CONCLUSIONS Magnetic capture and lavage evaluate CTXII in different ways: Magnetic capture measures total CTXII in the joint, while lavage measures concentration. Our data indicate magnetic capture may be advantageous at later time points, where CTXII can be diluted by effusions.
Collapse
Affiliation(s)
- E. G. Yarmola
- J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL
| | - Y. Y. Shah
- J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL,Department of Materials Science and Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL
| | - H. E. Kloefkorn
- J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL
| | - J. Dobson
- J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL,Department of Materials Science and Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL
| | - K. D. Allen
- J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL
| |
Collapse
|
19
|
Singleton R, Salkoski AJ, Bulkow L, Fish C, Dobson J, Albertson L, Skarada J, Kovesi T, McDonald C, Hennessy TW, Ritter T. Housing characteristics and indoor air quality in households of Alaska Native children with chronic lung conditions. Indoor Air 2017; 27:478-486. [PMID: 27317363 DOI: 10.1111/ina.12315] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/10/2016] [Accepted: 06/14/2016] [Indexed: 06/06/2023]
Abstract
Alaska Native children experience high rates of respiratory infections and conditions. Household crowding, indoor smoke, lack of piped water, and poverty have been associated with respiratory infections. We describe the baseline household characteristics of children with severe or chronic lung disease participating in a 2012-2015 indoor air study. We monitored indoor PM2.5, CO2 , relative humidity %, temperature, and VOCs and interviewed caregivers about children's respiratory symptoms. We evaluated the association between reported children's respiratory symptoms and indoor air quality indicators using multiple logistic regression analysis. Compared with general US households, study households were more likely overcrowded 73% (62%-82%) vs 3.2% (3.1%-3.3%); had higher woodstove use as primary heat source 16% (9%-25%) vs 2.1% (2.0%-2.2%); and higher proportion of children in a household with a smoker 49% (38%-60%) vs 26.2% (25.5%-26.8%). Median PM2.5 was 33 μg/m3 . Median CO2 was 1401 ppm. VOCs were detectable in all homes. VOCs, smoker, primary wood heat, and PM2.5>25 μg/m3 were associated with higher risk for cough between colds; VOCs were associated with higher risk for wheeze between colds and asthma diagnosis. High indoor air pollutant levels were associated with respiratory symptoms in household children, likely related to overcrowding, poor ventilation, woodstove use, and tobacco smoke.
Collapse
Affiliation(s)
- R Singleton
- Division of Community Health Services, Alaska Native Tribal Health Consortium (ANTHC), Anchorage, AK, USA
- Arctic Investigations Program, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA
| | - A J Salkoski
- Community Environment and Health, ANTHC, Anchorage, AK, USA
| | - L Bulkow
- Arctic Investigations Program, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA
| | - C Fish
- Division of Environmental Health and Engineering, ANTHC, Anchorage, AK, USA
| | - J Dobson
- Office of Environmental Health, Yukon Kuskokwim Health Corporation, Bethel, AK, USA
| | - L Albertson
- School of Natural Resources and Extension, University of Alaska, Fairbanks, Bethel, AK, USA
| | - J Skarada
- Bristol Bay Area Health Corporation, Dillingham, AK, USA
| | - T Kovesi
- Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada
| | - C McDonald
- Community Environment and Health, ANTHC, Anchorage, AK, USA
| | - T W Hennessy
- Arctic Investigations Program, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA
| | - T Ritter
- Division of Environmental Health and Engineering, ANTHC, Anchorage, AK, USA
- CDC/ONDIEh/NCEH, Environmental Health Services Branch, Atlanta, GA, USA
| |
Collapse
|
20
|
Tolaney SM, Forero-Torres A, Boni V, Bachelot T, Lu YS, Maur M, Fasolo A, Motta M, Pan C, Dobson J, Hewes B, Chin Lee S. Abstract P4-22-12: Ribociclib + fulvestrant in postmenopausal women with HR+, HER2– advanced breast cancer (ABC). Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p4-22-12] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Endocrine therapy (ET) is the treatment backbone for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) ABC, but efficacy is limited by ET resistance. The cyclin-dependent kinase (CDK) 4/6–cyclin D (CCND1)–retinoblastoma (Rb) and phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathways have been implicated in ET resistance. CDK4/6 and PI3K/mTOR inhibitors act synergistically with ET in preclinical and clinical studies of HR+ breast cancer. Ribociclib (LEE011; CDK4/6 inhibitor) + fulvestrant ± alpelisib (BYL719) or buparlisib (BKM120) in HR+, HER2– ABC is being investigated in a Phase Ib/II study (NCT02088684). Here, we present results from the ribociclib + fulvestrant combination, with intermittent and continuous ribociclib dosing.
Methods: Postmenopausal patients (pts) with HR+, HER2– ABC refractory to aromatase inhibitors received ribociclib intermittently (600 mg/day, 3-weeks-on/1-week-off; Arm A) or continuously (400 mg/day; Arm B; following Arm A safety evaluation) + fulvestrant (500 mg; Cycle 1 Day 1 and 15; subsequent cycles Day 1). Primary objective: dose-limiting toxicities (DLTs) to confirm the recommended Phase II dose of ribociclib + fulvestrant. Secondary objectives: safety, pharmacokinetics, and preliminary antitumor activity (RECIST v1.1); biomarkers that may correlate with response were also assessed.
Results: As of March 10, 2016, 24 pts received ribociclib + fulvestrant (Arm A, n=13; Arm B, n=11); 4 pts in Arm B were ongoing; median duration of exposure was 7.4 (Arm A) and 4.5 (Arm B) months. Median number of prior regimens: 4 (Arm A) and 3 (Arm B). Treatment discontinuation (n; Arm A, Arm B) was due to disease progression (11, 4), physician decision (1, 2), and adverse events (AEs; 1, 1). DLTs in Cycle 1 (n; Arm A, Arm B) were Grade [G] 3 pulmonary embolism (1, 0) and G3 aspartate aminotransferase elevation (0, 1). The most common G3/4 drug-related AE (Arm A, Arm B) was neutropenia (62%, 36%); 5 pts had QTcF prolongation >60 ms (n; 4, 1).
Common all-Grade drug-related AEs (>35% pts) n (%)Arm A (n=13)Arm B (n=11)Neutropenia10 (77)7 (64)Fatigue9 (69)3 (27)Nausea6 (46)5 (46)Anemia6 (46)0 (0)Reduced appetite5 (39)1 (9)
Best overall responses (BORs; n; Arm A, Arm B): partial response (PR; 3, 1), stable disease (SD; 9, 6), and neither complete response nor progressive disease (NCRNPD; non-measurable disease; 1, 4). Overall response rate: 23% (Arm A) and 9% (Arm B); disease control rate (BOR of complete response, PR, SD, or NCRNPD): 100% in both arms. Next-generation sequencing data (n; Arm A, Arm B) were available for 16 pts (7, 9): 5 pts had CCND1 alterations (PR [1, 0], SD [2, 1], and NCRNPD [0, 1]); 11 pts had PIK3CA alterations (PR [1, 0], SD [3, 4], and NCRNPD [1, 2]); 2 of these pts had both CCND1 and PIK3CA alterations (SD [1, 0] and NCRNPD [0, 1]).
Conclusions: Ribociclib + fulvestrant has a manageable safety profile and shows preliminary clinical activity in pretreated pts with HR+, HER2– ABC. Both ribociclib intermittent and continuous dosing schedules were well tolerated. Clinical responses were observed in tumors with and without CDK4/6–cyclin D–Rb and PI3K/mTOR pathway alterations.
Citation Format: Tolaney SM, Forero-Torres A, Boni V, Bachelot T, Lu Y-S, Maur M, Fasolo A, Motta M, Pan C, Dobson J, Hewes B, Chin Lee S. Ribociclib + fulvestrant in postmenopausal women with HR+, HER2– advanced breast cancer (ABC) [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P4-22-12.
Collapse
Affiliation(s)
- SM Tolaney
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - A Forero-Torres
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - V Boni
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - T Bachelot
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - Y-S Lu
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - M Maur
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - A Fasolo
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - M Motta
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - C Pan
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - J Dobson
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - B Hewes
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| | - S Chin Lee
- Dana-Faber Cancer Institute, Boston, MA; University of Alabama at Birmingham Hospital, Birmingham, AL; START Madrid-Centro Integral Oncológico Clara Campal Hospital, Madrid, Spain; Centre Léon Bérard, Lyon, France; National Taiwan University College of Medicine, Taipei, Taiwan; University Hospital of Modena and Reggio Emilia, Modena, Italy; San Raffaele Hospital, Milan, Italy; Novartis Institutes for BioMedical Research, Cambridge, MA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; National University Cancer Institute, National University Health System, Singapore
| |
Collapse
|
21
|
Marcinowska A, Constantino-Casas F, Williams T, Hoather T, Blacklaws B, Dobson J. T Lymphocytes in Histiocytic Sarcomas of Flat-Coated Retriever Dogs. Vet Pathol 2017; 54:605-610. [DOI: 10.1177/0300985817690208] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Flat-Coated Retriever dogs are predisposed to the development of histiocytic sarcoma (HS), a poorly differentiated, highly malignant neoplasm. The authors have previously documented a significant lymphocytic infiltrate in such tumors. The objective of this study was to examine the presence and expression of regulatory T cells in HS tumor samples. Forty tumors were included in this study. All tumors were immunolabeled for CD3, CD79a, CD25, CD45RA, and FOXP3. The proportion of positive cells was compared between tumors presenting as a localized primary soft tissue mass (soft tissue origin HS) and disseminated HS affecting viscera, especially the spleen (splenic origin HS). By immunohistochemistry, 95% of infiltrating T cells were positive for Foxp3 in all sections, suggesting the presence of regulatory T cells. The proportion of cells positive for FOXP3 was higher in the tumors arising in soft tissues, whereas the proportion of CD45RA-positive cells was higher in the splenic origin HS. Canine HS has an aggressive clinical behavior and is uniformly fatal. The difference in the proportion of tumor-infiltrating lymphocytes positive for these 2 markers in the 2 locations may represent differences in tumor microenvironment between the 2 sites.
Collapse
Affiliation(s)
- A. Marcinowska
- The Queen’s Veterinary School Hospital, University of Cambridge, Cambridge, UK
| | | | - T. Williams
- The Queen’s Veterinary School Hospital, University of Cambridge, Cambridge, UK
| | - T. Hoather
- The Queen’s Veterinary School Hospital, University of Cambridge, Cambridge, UK
| | - B. Blacklaws
- The Queen’s Veterinary School Hospital, University of Cambridge, Cambridge, UK
| | - J. Dobson
- The Queen’s Veterinary School Hospital, University of Cambridge, Cambridge, UK
| |
Collapse
|
22
|
Giuliano A, dos Santos Horta R, Constantino-Casas F, Hoather T, Dobson J. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours. J Comp Pathol 2017; 156:14-20. [DOI: 10.1016/j.jcpa.2016.10.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2016] [Revised: 09/29/2016] [Accepted: 10/19/2016] [Indexed: 10/20/2022]
|
23
|
Affiliation(s)
- J Dobson
- Department of Dermatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, U.K..
| | - C Ondhia
- Department of Dermatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, Praed St, London, W2 1NY, U.K
| | - A-M Skellett
- Department of Dermatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, U.K
| | - R Coelho
- Department of Dermatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, U.K
| |
Collapse
|
24
|
Wilkinson C, Terri R, Andreopoulos C, Bercellie A, Bronner C, Cartwright S, de Perio P, Dobson J, Duffy K, Furmanski A, Haegel L, Hayato Y, Kaboth A, Mahn K, McFarland K, Nowak J, Redij A, Rodrigues P, Sánchez F, Schwehr J, Sinclair P, Sobczyk J, Stamoulis P, Stowell P, Tacik R, Thompson L, Tobayama S, Wascko M, Żmuda J. Testing charged current quasi-elastic and multinucleon interaction models in the NEUT neutrino interaction generator with published datasets from the MiniBooNE and MINERνA experiments. Int J Clin Exp Med 2016. [DOI: 10.1103/physrevd.93.072010] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
25
|
Ramey AM, Pearce JM, Reeves AB, Poulson RL, Dobson J, Lefferts B, Spragens K, Stallknecht DE. Surveillance for Eurasian-origin and intercontinental reassortant highly pathogenic influenza A viruses in Alaska, spring and summer 2015. Virol J 2016; 13:55. [PMID: 27036114 PMCID: PMC4815243 DOI: 10.1186/s12985-016-0511-9] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2015] [Accepted: 03/21/2016] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Eurasian-origin and intercontinental reassortant highly pathogenic (HP) influenza A viruses (IAVs) were first detected in North America in wild, captive, and domestic birds during November-December 2014. Detections of HP viruses in wild birds in the contiguous United States and southern Canadian provinces continued into winter and spring of 2015 raising concerns that migratory birds could potentially disperse viruses to more northerly breeding areas where they could be maintained to eventually seed future poultry outbreaks. RESULTS We sampled 1,129 wild birds on the Yukon-Kuskokwim Delta, Alaska, one of the largest breeding areas for waterfowl in North America, during spring and summer of 2015 to test for Eurasian lineage and intercontinental reassortant HP H5 IAVs and potential progeny viruses. We did not detect HP IAVs in our sample collection from western Alaska; however, we isolated five low pathogenic (LP) viruses. Four isolates were of the H6N1 (n = 2), H6N2, and H9N2 combined subtypes whereas the fifth isolate was a mixed infection that included H3 and N7 gene segments. Genetic characterization of these five LP IAVs isolated from cackling (Branta hutchinsii; n = 2) and greater white-fronted geese (Anser albifrons; n = 3), revealed three viral gene segments sharing high nucleotide identity with HP H5 viruses recently detected in North America. Additionally, one of the five isolates was comprised of multiple Eurasian lineage gene segments. CONCLUSIONS Our results did not provide direct evidence for circulation of HP IAVs in the Yukon-Kuskokwim Delta region of Alaska during spring and summer of 2015. Prevalence and genetic characteristics of LP IAVs during the sampling period are concordant with previous findings of relatively low viral prevalence in geese during spring, non-detection of IAVs in geese during summer, and evidence for intercontinental exchange of viruses in western Alaska.
Collapse
Affiliation(s)
- Andrew M Ramey
- U.S. Geological Survey, Alaska Science Center, 4210 University Drive, Anchorage, AK, 99508, USA.
| | - John M Pearce
- U.S. Geological Survey, Alaska Science Center, 4210 University Drive, Anchorage, AK, 99508, USA
| | - Andrew B Reeves
- U.S. Geological Survey, Alaska Science Center, 4210 University Drive, Anchorage, AK, 99508, USA
| | - Rebecca L Poulson
- Southeastern Cooperative Wildlife Disease Study, Department of Population Health, College of Veterinary Medicine, 589 D. W. Brooks Drive, University of Georgia, Athens, GA, 30602, USA
| | - Jennifer Dobson
- Yukon-Kuskokwim Health Corporation, 900 Chief Eddie Hoffman Highway, Bethel, AK, 99559, USA
| | - Brian Lefferts
- Yukon-Kuskokwim Health Corporation, 900 Chief Eddie Hoffman Highway, Bethel, AK, 99559, USA
| | - Kyle Spragens
- U.S. Geological Survey, Western Ecological Research Center, San Francisco Bay Estuary, 505 Azuar Drive, Vallejo, CA, 94592, USA
- U.S. Fish and Wildlife Service, Yukon Delta National Wildlife Refuge, 807 Chief Eddie Hoffman Highway, Bethel, AK, 99559, USA
| | - David E Stallknecht
- Southeastern Cooperative Wildlife Disease Study, Department of Population Health, College of Veterinary Medicine, 589 D. W. Brooks Drive, University of Georgia, Athens, GA, 30602, USA
| |
Collapse
|
26
|
Thomas TK, Ritter T, Bruden D, Bruce M, Byrd K, Goldberger R, Dobson J, Hickel K, Smith J, Hennessy T. Impact of providing in-home water service on the rates of infectious diseases: results from four communities in Western Alaska. J Water Health 2016; 14:132-141. [PMID: 26837837 PMCID: PMC5557094 DOI: 10.2166/wh.2015.110] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Approximately 20% of rural Alaskan homes lack in-home piped water; residents haul water to their homes. The limited quantity of water impacts the ability to meet basic hygiene needs. We assessed rates of infections impacted by water quality (waterborne, e.g. gastrointestinal infections) and quantity (water-washed, e.g. skin and respiratory infections) in communities transitioning to in-home piped water. Residents of four communities consented to a review of medical records 3 years before and after their community received piped water. We selected health encounters with ICD-9CM codes for respiratory, skin and gastrointestinal infections. We calculated annual illness episodes for each infection category after adjusting for age. We obtained 5,477 person-years of observation from 1032 individuals. There were 9,840 illness episodes with at least one ICD-9CM code of interest; 8,155 (83%) respiratory, 1,666 (17%) skin, 241 (2%) gastrointestinal. Water use increased from an average 1.5 gallons/capita/day (g/c/d) to 25.7 g/c/d. There were significant (P-value < 0.05) declines in respiratory (16, 95% confidence interval (CI): 11-21%), skin (20, 95%CI: 10-30%), and gastrointestinal infections (38, 95%CI: 13-55%). We demonstrated significant declines in respiratory, skin and gastrointestinal infections among individuals who received in-home piped water. This study reinforces the importance of adequate quantities of water for health.
Collapse
Affiliation(s)
- T K Thomas
- Alaska Native Tribal Health Consortium, 3900 Ambassador Drive, Anchorage, Alaska, 99508, USA E-mail:
| | - T Ritter
- Alaska Native Tribal Health Consortium, 3900 Ambassador Drive, Anchorage, Alaska, 99508, USA E-mail:
| | - D Bruden
- Centers for Disease Control and Prevention, Arctic Investigation Program, 4055 Tudor Center Drive, Anchorage, Alaska, 99508, USA
| | - M Bruce
- Centers for Disease Control and Prevention, Arctic Investigation Program, 4055 Tudor Center Drive, Anchorage, Alaska, 99508, USA
| | - K Byrd
- Centers for Disease Control and Prevention, Arctic Investigation Program, 4055 Tudor Center Drive, Anchorage, Alaska, 99508, USA
| | - R Goldberger
- Alaska Native Tribal Health Consortium, 3900 Ambassador Drive, Anchorage, Alaska, 99508, USA E-mail:
| | - J Dobson
- Yukon Kuskokwim Health Corporation, P.O. Box 528, Bethel, Alaska, 99559, USA
| | - K Hickel
- Alaska Native Tribal Health Consortium, 3900 Ambassador Drive, Anchorage, Alaska, 99508, USA E-mail:
| | - J Smith
- Alaska Native Tribal Health Consortium, 3900 Ambassador Drive, Anchorage, Alaska, 99508, USA E-mail:
| | - T Hennessy
- Centers for Disease Control and Prevention, Arctic Investigation Program, 4055 Tudor Center Drive, Anchorage, Alaska, 99508, USA
| |
Collapse
|
27
|
Reardon RJM, Dixon PM, Kane-Smyth J, Froydenlund T, Booth SA, Dobson J, Smith K. Combined surgical and radiotherapy treatment of a mandibular ameloblastic carcinoma in a pony. EQUINE VET EDUC 2016. [DOI: 10.1111/eve.12535] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- R. J. M. Reardon
- Equine Hospital; Royal (Dick) School of Veterinary Studies; University of Edinburgh; Midlothian UK
| | - P. M. Dixon
- Equine Hospital; Royal (Dick) School of Veterinary Studies; University of Edinburgh; Midlothian UK
| | - J. Kane-Smyth
- Equine Hospital; Royal (Dick) School of Veterinary Studies; University of Edinburgh; Midlothian UK
| | - T. Froydenlund
- Equine Hospital; Royal (Dick) School of Veterinary Studies; University of Edinburgh; Midlothian UK
| | - S. A. Booth
- Robson & Prescott; The Veterinary Centre; Morpeth Northumberland UK
| | - J. Dobson
- Department of Veterinary Medicine; Cambridge Equine Hospital; University of Cambridge; UK
| | - K. Smith
- Department of Veterinary Medicine; Cambridge Equine Hospital; University of Cambridge; UK
| |
Collapse
|
28
|
Doig D, Turner E, Dobson J, Featherstone R, de Borst G, Stansby G, Beard J, Engelter S, Richards T, Brown M. Risk Factors For Stroke, Myocardial Infarction, or Death Following Carotid Endarterectomy: Results From the International Carotid Stenting Study. J Vasc Surg 2015. [DOI: 10.1016/j.jvs.2015.10.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
29
|
Bonati L, Dobson J, Featherstone R. Long-Term Outcomes After Stenting Versus Endarterectomy for Treatment of Symptomatic Carotid Stenosis: The International Carotid Stenting Study (ICSS) Randomised Trial. J Vasc Surg 2015. [DOI: 10.1016/j.jvs.2015.09.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
30
|
Doig D, Turner EL, Dobson J, Featherstone RL, Lo RTH, Gaines PA, Macdonald S, Bonati LH, Clifton A, Brown MM. Predictors of Stroke, Myocardial Infarction or Death within 30 Days of Carotid Artery Stenting: Results from the International Carotid Stenting Study. Eur J Vasc Endovasc Surg 2015; 51:327-34. [PMID: 26602322 PMCID: PMC4786052 DOI: 10.1016/j.ejvs.2015.08.013] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2014] [Accepted: 08/18/2015] [Indexed: 10/25/2022]
Abstract
OBJECTIVES Stroke, myocardial infarction (MI), and death are complications of carotid artery stenting (CAS). The effect of baseline patient demographic factors, processes of care, and technical factors during CAS on the risk of stroke, MI, or death within 30 days of CAS in the International Carotid Stenting Study (ICSS) were investigated. METHODS In ICSS, suitable patients with recently symptomatic carotid stenosis > 50% were randomly allocated to CAS or endarterectomy. Factors influencing the risk of stroke, MI, or death within 30 days of CAS were examined in a regression model for the 828 patients randomized to CAS in whom the procedure was initiated. RESULTS Of the patients, 7.4% suffered stroke, MI, or death within 30 days of CAS. Independent predictors of risk were age (risk ratio [RR] 1.17 per 5 years of age, 95% CI 1.01-1.37), a right-sided procedure (RR 0.54, 95% CI 0.32-0.91), aspirin and clopidogrel in combination prior to CAS (compared with any other antiplatelet regimen, RR 0.59, 95% CI 0.36-0.98), smoking status, and the severity of index event. In patients in whom a stent was deployed, use of an open-cell stent conferred higher risk than use of a closed-cell stent (RR 1.92, 95% CI 1.11-3.33). Cerebral protection device (CPD) use did not modify the risk. CONCLUSIONS Selection of patients for CAS should take into account symptoms, age, and side of the procedure. The results favour the use of closed-cell stents. CPDs in ICSS did not protect against stroke.
Collapse
Affiliation(s)
- D Doig
- Institute of Neurology, University College London, UK
| | - E L Turner
- Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA; Duke Global Health Institute, Duke University, Durham, NC, USA
| | - J Dobson
- Department of Medical Statistics, London School of Hygiene and Tropical Medicine, UK
| | | | - R T H Lo
- University Medical Centre, Utrecht, The Netherlands
| | - P A Gaines
- Sheffield Vascular Institute, Sheffield, UK
| | - S Macdonald
- Freeman Hospital, Newcastle Acute Hospitals NHS Foundation Trust, Newcastle, UK
| | - L H Bonati
- Institute of Neurology, University College London, UK; Department of Neurology and Stroke Unit, University Hospital Basel, Switzerland
| | | | - M M Brown
- Institute of Neurology, University College London, UK.
| | | |
Collapse
|
31
|
Doig D, Turner EL, Dobson J, Featherstone RL, de Borst GJ, Stansby G, Beard JD, Engelter ST, Richards T, Brown MM. Risk Factors For Stroke, Myocardial Infarction, or Death Following Carotid Endarterectomy: Results From the International Carotid Stenting Study. Eur J Vasc Endovasc Surg 2015; 50:688-94. [PMID: 26460291 PMCID: PMC4684145 DOI: 10.1016/j.ejvs.2015.08.006] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2014] [Accepted: 08/10/2015] [Indexed: 11/29/2022]
Abstract
OBJECTIVES Carotid endarterectomy (CEA) is standard treatment for symptomatic carotid artery stenosis but carries a risk of stroke, myocardial infarction (MI), or death. This study investigated risk factors for these procedural complications occurring within 30 days of endarterectomy in the International Carotid Stenting Study (ICSS). METHODS Patients with recently symptomatic carotid stenosis >50% were randomly allocated to endarterectomy or stenting. Analysis is reported of patients in ICSS assigned to endarterectomy and limited to those in whom CEA was initiated. The occurrence of stroke, MI, or death within 30 days of the procedure was reported by investigators and adjudicated. Demographic and technical risk factors for these complications were analysed sequentially in a binomial regression analysis and subsequently in a multivariable model. RESULTS Eight-hundred and twenty-one patients were included in the analysis. The risk of stroke, MI, or death within 30 days of CEA was 4.0%. The risk was higher in female patients (risk ratio [RR] 1.98, 95% CI 1.02-3.87, p = .05) and with increasing baseline diastolic blood pressure (dBP) (RR 1.30 per +10 mmHg, 95% CI 1.02-1.66, p = .04). Mean baseline dBP, obtained at the time of randomization in the trial, was 78 mmHg (SD 13 mmHg). In a multivariable model, only dBP remained a significant predictor. The risk was not related to the type of surgical reconstruction, anaesthetic technique, or perioperative medication regimen. Patients undergoing CEA stayed a median of 4 days before discharge, and 21.2% of events occurred on or after the day of discharge. CONCLUSIONS Increasing diastolic blood pressure was the only independent risk factor for stroke, MI, or death following CEA. Cautious attention to blood pressure control following symptoms attributable to carotid stenosis could reduce the risks associated with subsequent CEA.
Collapse
Affiliation(s)
- D Doig
- Institute of Neurology, University College London, UK
| | - E L Turner
- Department of Biostatistics and Bioinformatics and Duke Global Health Institute, Duke University, Durham, NC, USA
| | - J Dobson
- Department of Medical Statistics, London School of Hygiene and Tropical Medicine, UK
| | | | - G J de Borst
- Department of Vascular Surgery, University Medical Centre Utrecht, The Netherlands
| | - G Stansby
- Department of Vascular Surgery, Freeman Hospital, Newcastle upon Tyne, UK
| | - J D Beard
- Sheffield Vascular Institute, Northern General Hospital, Sheffield, UK
| | - S T Engelter
- Department of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland
| | - T Richards
- Division of Surgery and Interventional Science, University College London, UK
| | - M M Brown
- Institute of Neurology, University College London, UK.
| | | |
Collapse
|
32
|
Pifko E, Busch C, Price A, Smith C, Dobson J, Losek J, Tecklenberg F, Tuuri R. 240 An Observational Review of Pediatric Intraosseous Needle Placement in the Pediatric Emergency Department. Ann Emerg Med 2015. [DOI: 10.1016/j.annemergmed.2015.07.273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
33
|
Giuliano A, Salgüero R, Dobson J. Metastatic anal sac carcinoma with hypercalcaemia and associated hypertrophic osteopathy in a dog. Open Vet J 2015; 5:48-51. [PMID: 26623365 PMCID: PMC4629575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2015] [Accepted: 04/08/2015] [Indexed: 10/26/2022] Open
Abstract
A seven-year-old male neutered Irish setter was treated for a metastatic anal sac adenocarcinoma (ASAC) and hypercalcaemia by complete surgical excision of the primary tumour and partial excision of the sublumbar lymph nodes. Further enlargement of the sublumbar lymph nodes was linked to recurrent hypercalcaemia 3 months after surgical treatment. Medical treatment with Toceranib and Clodronate showed modest results in the treatment of the tumour and the hypercalcaemia. Radiotherapy of the sublumbar lymph nodes and later concurrent carboplatin chemotherapy resulted in partial tumour remission with marked reduction in size of the lymph nodes and normalization of the calcaemia. Unfortunately, concurrently with subsequent relapse of the hypercalaemia, the dog developed hypertrophic osteopathy (HO) and lumbar spinal metastasis and the dog was euthanized. To the authors' knowledge, this is the second case of metastatic apocrine gland carcinoma of the anal sac associated with HO and the first case that describe the development of HO late in the stage of the disease.
Collapse
Affiliation(s)
- A. Giuliano
- Queen’s Veterinary School Hospital, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, United Kingdom
| | - R. Salgüero
- Queen’s Veterinary School Hospital, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, United Kingdom
| | - J. Dobson
- Queen’s Veterinary School Hospital, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, United Kingdom
| |
Collapse
|
34
|
van Lelyveld S, Warland J, Miller R, Maw H, Foale R, Goodfellow M, Dobson J. Comparison between Ki-67 index and mitotic index for predicting outcome in canine mast cell tumours. J Small Anim Pract 2015; 56:312-9. [DOI: 10.1111/jsap.12320] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2014] [Revised: 11/30/2014] [Accepted: 12/01/2014] [Indexed: 01/07/2023]
Affiliation(s)
- S. van Lelyveld
- Dovecote Veterinary Hospital; 5 Delven Lane, Derby Castle Donington Derby DE74 2LJ
- Davies Veterinary Specialists, Manor Farm Business Park; Higham Gobion, Hitchin Hertfordshire SG5 3HR
| | - J. Warland
- Department of Veterinary Medicine; University of Cambridge; Cambridge CB3 OES
| | - R. Miller
- Dick White Referrals, Station Farm; Six Mile Bottom Cambridgeshire CB8 0UH
| | - H. Maw
- Department of Veterinary Medicine; University of Cambridge; Cambridge CB3 OES
| | - R. Foale
- Dick White Referrals, Station Farm; Six Mile Bottom Cambridgeshire CB8 0UH
| | - M. Goodfellow
- Davies Veterinary Specialists, Manor Farm Business Park; Higham Gobion, Hitchin Hertfordshire SG5 3HR
| | - J. Dobson
- Department of Veterinary Medicine; University of Cambridge; Cambridge CB3 OES
| |
Collapse
|
35
|
Ritter TL, Lopez EDS, Goldberger R, Dobson J, Hickel K, Smith J, Johnson RM, Bersamin A. Consuming untreated water in four southwestern Alaska Native communities: reasons revealed and recommendations for change. J Environ Health 2014; 77:8-52. [PMID: 25619021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
In this article, the authors provide the first in-depth account of why some Alaska Native people drink untreated water when treated water is available. Their qualitative research was conducted in four Alaska Native village communities that have treated water available from a centralized distribution point. Most respondents (n = 172; 82%) reported that some of their household's drinking water came from an untreated source. Motives for drinking untreated water emerged from analysis of open-ended questions about drinking water practice and could be categorized into six themes: chemicals, taste, health, access, tradition, and cost. Importantly, some residents reported consuming untreated water because they both liked untreated water and disliked treated water. As such, interventions to increase safe water consumption should address this dichotomy by providing education about the benefits of treated water alongside the risks involved with drinking untreated water. Based on the findings, the authors provide specific recommendations for developing behavior change interventions that address influences at multiple social-ecological levels.
Collapse
|
36
|
Doig D, Turner EL, Dobson J, Featherstone RL, de Borst GJ, Brown MM, Richards T. Incidence, impact, and predictors of cranial nerve palsy and haematoma following carotid endarterectomy in the international carotid stenting study. Eur J Vasc Endovasc Surg 2014; 48:498-504. [PMID: 25344019 PMCID: PMC4225222 DOI: 10.1016/j.ejvs.2014.08.002] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2014] [Accepted: 08/01/2014] [Indexed: 11/21/2022]
Abstract
OBJECTIVE Cranial nerve palsy (CNP) and neck haematoma are complications of carotid endarterectomy (CEA). The effects of patient factors and surgical technique were analysed on the risk, and impact on disability, of CNP or haematoma in the surgical arm of the International Carotid Stenting Study (ICSS), a randomized controlled clinical trial of stenting versus CEA in patients with symptomatic carotid stenosis. MATERIALS AND METHODS A per-protocol analysis of early outcome in patients receiving CEA in ICSS is reported. Haematoma was defined by the surgeon. CNP was confirmed by an independent neurologist. Factors associated with the risk of CNP and haematoma were investigated in a binomial regression analysis. RESULTS Of the patients undergoing CEA, 45/821 (5.5%) developed CNP, one of which was disabling (modified Rankin score = 3 at 1 month). Twenty-eight (3.4%) developed severe haematoma. Twelve patients with haematoma also had CNP, a significant association (p < .01). Independent risk factors modifying the risk of CNP were cardiac failure (risk ratio [RR] 2.66, 95% CI 1.11 to 6.40), female sex (RR 1.80, 95% CI 1.02 to 3.20), the degree of contralateral carotid stenosis, and time from randomization to treatment >14 days (RR 3.33, 95% CI 1.05 to 10.57). The risk of haematoma was increased in women, by the prescription of anticoagulant drugs pre-procedure and in patients with atrial fibrillation, and was decreased in patients in whom a shunt was used and in those with a higher baseline cholesterol level. CONCLUSIONS CNP remains relatively common after CEA, but is rarely disabling. Women should be warned about an increased risk. Attention to haemostasis might reduce the incidence of CNP. ICSS is a registered clinical trial: ISRCTN 25337470.
Collapse
Affiliation(s)
- D Doig
- Institute of Neurology, University College London, London, UK
| | - E L Turner
- Department of Biostatistics and Bioinformatics and Duke Global Health Institute, Duke University, Durham, NC, USA
| | - J Dobson
- Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK
| | | | - G J de Borst
- Department of Vascular Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - M M Brown
- Institute of Neurology, University College London, London, UK.
| | - T Richards
- Department of Surgical and Interventional Sciences, University College London, London, UK
| |
Collapse
|
37
|
Rayner L, Matcham F, Hutton J, Stringer C, Dobson J, Steer S, Hotopf M. Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder. Gen Hosp Psychiatry 2014; 36:318-24. [PMID: 24630892 DOI: 10.1016/j.genhosppsych.2013.12.004] [Citation(s) in RCA: 99] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/30/2013] [Revised: 11/15/2013] [Accepted: 12/05/2013] [Indexed: 01/27/2023]
Abstract
OBJECTIVE To assess the feasibility and acceptability of routine web-based screening in general hospital settings, and describe the level of common mental disorder. METHOD A service development platform to integrate mental and physical healthcare was implemented in six specialties (rheumatology, limb reconstruction, hepatitis C, psoriasis, adult congenital heart disease (ACHD), chronic pain) across three general hospitals in London, UK. Under service conditions, patients completed a web-based questionnaire comprising mental and physical patient-reported outcome measures, whilst waiting for their appointment. Feasibility was quantified as the proportion of patients who completed the questionnaire. Acceptability was quantified as the proportion of patients declining screening, and the proportion requiring assistance completing the questionnaire. The prevalence of probable depression and anxiety was expressed as the percentage of cases determined by the Patient Health Questionnaire-9 and Generalised Anxiety Disorder Questionnaire-7. RESULTS The proportion of patients screened varied widely across specialties (40.1-98.2%). The decline rate was low (0.6-9.7%) and the minority required assistance (11.7-40.4%). The prevalence of probable depression ranged from 60.9% in chronic pain to 6.6% in ACHD. The prevalence of probable anxiety ranged from 25.1% in rheumatology to 11.4% in ACHD. CONCLUSION Web-based screening is acceptable to patients and can be effectively embedded in routine practice. General hospital patients are at increased risk of common mental disorder, and routine screening may help identify need, inform care and monitor outcomes.
Collapse
Affiliation(s)
- L Rayner
- Department of Psychological Medicine, Institute of Psychiatry, King's College London, SE5 9RJ London, UK.
| | - F Matcham
- Department of Psychological Medicine, Institute of Psychiatry, King's College London, SE5 9RJ London, UK
| | - J Hutton
- South London and Maudsley and King's College Hospital NHS Foundation Trusts, UK
| | - C Stringer
- Information and Communication Technology, King's College Hospital NHS Foundation Trust, UK
| | - J Dobson
- Department of Rheumatology, School of Medicine, King's College London, UK
| | - S Steer
- Department of Rheumatology, School of Medicine, King's College London, UK
| | - M Hotopf
- Department of Psychological Medicine, Institute of Psychiatry, King's College London, SE5 9RJ London, UK
| |
Collapse
|
38
|
Everett J, Céspedes E, Shelford LR, Exley C, Collingwood JF, Dobson J, van der Laan G, Jenkins CA, Arenholz E, Telling ND. Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1-42). J R Soc Interface 2014; 11:20140165. [PMID: 24671940 PMCID: PMC4006257 DOI: 10.1098/rsif.2014.0165] [Citation(s) in RCA: 88] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
For decades, a link between increased levels of iron and areas of Alzheimer's disease (AD) pathology has been recognized, including AD lesions comprised of the peptide β-amyloid (Aβ). Despite many observations of this association, the relationship between Aβ and iron is poorly understood. Using X-ray microspectroscopy, X-ray absorption spectroscopy, electron microscopy and spectrophotometric iron(II) quantification techniques, we examine the interaction between Aβ(1–42) and synthetic iron(III), reminiscent of ferric iron stores in the brain. We report Aβ to be capable of accumulating iron(III) within amyloid aggregates, with this process resulting in Aβ-mediated reduction of iron(III) to a redox-active iron(II) phase. Additionally, we show that the presence of aluminium increases the reductive capacity of Aβ, enabling the redox cycling of the iron. These results demonstrate the ability of Aβ to accumulate iron, offering an explanation for previously observed local increases in iron concentration associated with AD lesions. Furthermore, the ability of iron to form redox-active iron phases from ferric precursors provides an origin both for the redox-active iron previously witnessed in AD tissue, and the increased levels of oxidative stress characteristic of AD. These interactions between Aβ and iron deliver valuable insights into the process of AD progression, which may ultimately provide targets for disease therapies.
Collapse
Affiliation(s)
- J Everett
- Institute for Science and Technology in Medicine, Keele University, , Stoke-on-Trent, Staffordshire ST4 7QB, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Bedikian S, Bernard E, Bernstein A, Bolozdynya A, Bradley A, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chapman JJ, Chiller AA, Chiller C, Clark K, Coffey T, Currie A, Curioni A, Dazeley S, de Viveiros L, Dobi A, Dobson J, Dragowsky EM, Druszkiewicz E, Edwards B, Faham CH, Fiorucci S, Flores C, Gaitskell RJ, Gehman VM, Ghag C, Gibson KR, Gilchriese MGD, Hall C, Hanhardt M, Hertel SA, Horn M, Huang DQ, Ihm M, Jacobsen RG, Kastens L, Kazkaz K, Knoche R, Kyre S, Lander R, Larsen NA, Lee C, Leonard DS, Lesko KT, Lindote A, Lopes MI, Lyashenko A, Malling DC, Mannino R, McKinsey DN, Mei DM, Mock J, Moongweluwan M, Morad J, Morii M, Murphy ASJ, Nehrkorn C, Nelson H, Neves F, Nikkel JA, Ott RA, Pangilinan M, Parker PD, Pease EK, Pech K, Phelps P, Reichhart L, Shutt T, Silva C, Skulski W, Sofka CJ, Solovov VN, Sorensen P, Stiegler T, O'Sullivan K, Sumner TJ, Svoboda R, Sweany M, Szydagis M, Taylor D, Tennyson B, Tiedt DR, Tripathi M, Uvarov S, Verbus JR, Walsh N, Webb R, White JT, White D, Witherell MS, Wlasenko M, Wolfs FLH, Woods M, Zhang C. First results from the LUX dark matter experiment at the Sanford underground research facility. Phys Rev Lett 2014; 112:091303. [PMID: 24655239 DOI: 10.1103/physrevlett.112.091303] [Citation(s) in RCA: 116] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/30/2013] [Indexed: 06/03/2023]
Abstract
The Large Underground Xenon (LUX) experiment is a dual-phase xenon time-projection chamber operating at the Sanford Underground Research Facility (Lead, South Dakota). The LUX cryostat was filled for the first time in the underground laboratory in February 2013. We report results of the first WIMP search data set, taken during the period from April to August 2013, presenting the analysis of 85.3 live days of data with a fiducial volume of 118 kg. A profile-likelihood analysis technique shows our data to be consistent with the background-only hypothesis, allowing 90% confidence limits to be set on spin-independent WIMP-nucleon elastic scattering with a minimum upper limit on the cross section of 7.6 × 10(-46) cm(2) at a WIMP mass of 33 GeV/c(2). We find that the LUX data are in disagreement with low-mass WIMP signal interpretations of the results from several recent direct detection experiments.
Collapse
Affiliation(s)
- D S Akerib
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - H M Araújo
- High Energy Physics, Imperial College London, Blackett Laboratory, London SW7 2BZ, United Kingdom
| | - X Bai
- South Dakota School of Mines and Technology, 501 East St Joseph Street, Rapid City, South Dakota 57701, USA
| | - A J Bailey
- High Energy Physics, Imperial College London, Blackett Laboratory, London SW7 2BZ, United Kingdom
| | - J Balajthy
- Department of Physics, University of Maryland, College Park, Maryland 20742, USA
| | - S Bedikian
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - E Bernard
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - A Bernstein
- Lawrence Livermore National Laboratory, 7000 East Avenue, Livermore, California 94550, USA
| | - A Bolozdynya
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - A Bradley
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - D Byram
- Department of Physics, University of South Dakota, 414E Clark Street, Vermillion, South Dakota 57069, USA
| | - S B Cahn
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - M C Carmona-Benitez
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA and Department of Physics, University of California Santa Barbara, Santa Barbara, California 93106, USA
| | - C Chan
- Department of Physics, Brown University, 182 Hope Street, Providence, Rhode Island 02912, USA
| | - J J Chapman
- Department of Physics, Brown University, 182 Hope Street, Providence, Rhode Island 02912, USA
| | - A A Chiller
- Department of Physics, University of South Dakota, 414E Clark Street, Vermillion, South Dakota 57069, USA
| | - C Chiller
- Department of Physics, University of South Dakota, 414E Clark Street, Vermillion, South Dakota 57069, USA
| | - K Clark
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - T Coffey
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - A Currie
- High Energy Physics, Imperial College London, Blackett Laboratory, London SW7 2BZ, United Kingdom
| | - A Curioni
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - S Dazeley
- Lawrence Livermore National Laboratory, 7000 East Avenue, Livermore, California 94550, USA
| | - L de Viveiros
- LIP-Coimbra, Department of Physics, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - A Dobi
- Department of Physics, University of Maryland, College Park, Maryland 20742, USA
| | - J Dobson
- SUPA, School of Physics and Astronomy, University of Edinburgh, Edinburgh, EH9 3JZ, United Kingdom
| | - E M Dragowsky
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - E Druszkiewicz
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - B Edwards
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - C H Faham
- Department of Physics, Brown University, 182 Hope Street, Providence, Rhode Island 02912, USA and Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | - S Fiorucci
- Department of Physics, Brown University, 182 Hope Street, Providence, Rhode Island 02912, USA
| | - C Flores
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - R J Gaitskell
- Department of Physics, Brown University, 182 Hope Street, Providence, Rhode Island 02912, USA
| | - V M Gehman
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | - C Ghag
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - K R Gibson
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - M G D Gilchriese
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | - C Hall
- Department of Physics, University of Maryland, College Park, Maryland 20742, USA
| | - M Hanhardt
- South Dakota School of Mines and Technology, 501 East St Joseph Street, Rapid City, South Dakota 57701, USA and South Dakota Science and Technology Authority, Sanford Underground Research Facility, Lead, South Dakota 57754, USA
| | - S A Hertel
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - M Horn
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - D Q Huang
- Department of Physics, Brown University, 182 Hope Street, Providence, Rhode Island 02912, USA
| | - M Ihm
- Department of Physics, University of California Berkeley, Berkeley, California 94720, USA
| | - R G Jacobsen
- Department of Physics, University of California Berkeley, Berkeley, California 94720, USA
| | - L Kastens
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - K Kazkaz
- Lawrence Livermore National Laboratory, 7000 East Avenue, Livermore, California 94550, USA
| | - R Knoche
- Department of Physics, University of Maryland, College Park, Maryland 20742, USA
| | - S Kyre
- Department of Physics, University of California Santa Barbara, Santa Barbara, California 93106, USA
| | - R Lander
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - N A Larsen
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - C Lee
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - D S Leonard
- Department of Physics, University of Maryland, College Park, Maryland 20742, USA
| | - K T Lesko
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | - A Lindote
- LIP-Coimbra, Department of Physics, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - M I Lopes
- LIP-Coimbra, Department of Physics, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - A Lyashenko
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - D C Malling
- Department of Physics, Brown University, 182 Hope Street, Providence, Rhode Island 02912, USA
| | - R Mannino
- Department of Physics, Texas A & M University, College Station, Texas 77843, USA
| | - D N McKinsey
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - D-M Mei
- Department of Physics, University of South Dakota, 414E Clark Street, Vermillion, South Dakota 57069, USA
| | - J Mock
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - M Moongweluwan
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - J Morad
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - M Morii
- Department of Physics, Harvard University, 17 Oxford Street, Cambridge, Massachusetts 02138, USA
| | - A St J Murphy
- SUPA, School of Physics and Astronomy, University of Edinburgh, Edinburgh, EH9 3JZ, United Kingdom
| | - C Nehrkorn
- Department of Physics, University of California Santa Barbara, Santa Barbara, California 93106, USA
| | - H Nelson
- Department of Physics, University of California Santa Barbara, Santa Barbara, California 93106, USA
| | - F Neves
- LIP-Coimbra, Department of Physics, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - J A Nikkel
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - R A Ott
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - M Pangilinan
- Department of Physics, Brown University, 182 Hope Street, Providence, Rhode Island 02912, USA
| | - P D Parker
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - E K Pease
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - K Pech
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - P Phelps
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - L Reichhart
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - T Shutt
- Department of Physics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA
| | - C Silva
- LIP-Coimbra, Department of Physics, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - W Skulski
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - C J Sofka
- Department of Physics, Texas A & M University, College Station, Texas 77843, USA
| | - V N Solovov
- LIP-Coimbra, Department of Physics, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - P Sorensen
- Lawrence Livermore National Laboratory, 7000 East Avenue, Livermore, California 94550, USA
| | - T Stiegler
- Department of Physics, Texas A & M University, College Station, Texas 77843, USA
| | - K O'Sullivan
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - T J Sumner
- High Energy Physics, Imperial College London, Blackett Laboratory, London SW7 2BZ, United Kingdom
| | - R Svoboda
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - M Sweany
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - M Szydagis
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - D Taylor
- South Dakota Science and Technology Authority, Sanford Underground Research Facility, Lead, South Dakota 57754, USA
| | - B Tennyson
- Department of Physics, Yale University, 217 Prospect Street, New Haven, Connecticut 06511, USA
| | - D R Tiedt
- South Dakota School of Mines and Technology, 501 East St Joseph Street, Rapid City, South Dakota 57701, USA
| | - M Tripathi
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - S Uvarov
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - J R Verbus
- Department of Physics, Brown University, 182 Hope Street, Providence, Rhode Island 02912, USA
| | - N Walsh
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - R Webb
- Department of Physics, Texas A & M University, College Station, Texas 77843, USA
| | - J T White
- Department of Physics, Texas A & M University, College Station, Texas 77843, USA
| | - D White
- Department of Physics, University of California Santa Barbara, Santa Barbara, California 93106, USA
| | - M S Witherell
- Department of Physics, University of California Santa Barbara, Santa Barbara, California 93106, USA
| | - M Wlasenko
- Department of Physics, Harvard University, 17 Oxford Street, Cambridge, Massachusetts 02138, USA
| | - F L H Wolfs
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - M Woods
- Department of Physics, University of California Davis, One Shields Avenue, Davis, California 95616, USA
| | - C Zhang
- Department of Physics, University of South Dakota, 414E Clark Street, Vermillion, South Dakota 57069, USA
| |
Collapse
|
40
|
Calvet D, Mas JL, Algra A, Becquemin JP, Bonati LH, Dobson J, Fraedrich G, Jansen O, Mali WP, Ringleb PA, Chatellier G, Brown MM, Calvet D, Mas JL, Algra A, Becquemin JP, Bonati L, Dobson J, Fraedrich G, Jansen O, Mali W, Ringleb P, Chatellier G, Brown M, Algra A, Becquemin J, Chatellier G, Mas JL, Fraedrich G, Ringleb P, Jansen O, Bonati LH, Brown MM, Mali WP, Mas JL, Chatellier G, Becquemin JP, Bonneville JF, Branchereau A, Crochet D, Gaux JC, Larrue V, Leys D, Watelet J, Hacke W, Hennerici M, Allenberg J, Maurer P, Eckstein HH, Zeumer H, Jansen O, Algra A, Bamford J, Beard J, Bland M, Bradbury A, Brown M, Clifton A, Gaines P, Hacke W, Halliday A, Malik I, Mas JL, McGuire A, Sidhu P, Venables G. Carotid Stenting. Stroke 2014; 45:527-32. [DOI: 10.1161/strokeaha.113.003526] [Citation(s) in RCA: 70] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- David Calvet
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Jean-Louis Mas
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Ale Algra
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Jean-Pierre Becquemin
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Leo H. Bonati
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Joanna Dobson
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Gustav Fraedrich
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Olav Jansen
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Willem P. Mali
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Peter A. Ringleb
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Gilles Chatellier
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - Martin M. Brown
- From the Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France (D.C., J.-L.M.); Department of Neurology and Julius Centre for Health Sciences and Patient Care (A.A.) and Department of Radiology (W.P.M.), University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Vascular Surgery, University Hospital Henri Mondor, Creteil, France (J.-P.B.); Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland (L.H.B.)
| | - D. Calvet
- Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France
| | - J.-L. Mas
- Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, INSERM UMR894, Paris, France
| | - A. Algra
- Department of Neurology and Julius Centre for Health Sciences and Patient Care, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - J.-P. Becquemin
- Department of Vascular Surgery, University Hospital Henri Mondor, 94010 Creteil, France
| | - L.H. Bonati
- Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland; and Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, London, United Kingdom
| | - J. Dobson
- Medical Statistics Unit, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
| | - G. Fraedrich
- Department of Vascular Surgery, Medical University, Innsbruck, Austria
| | - O. Jansen
- Department of Neuroradiology, Schleswig-Holstein University Hospital, Kiel, Germany
| | - W.P. Mali
- Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - P.A. Ringleb
- Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany
| | - G. Chatellier
- Clinical Research Unit, Hôpital Européen Georges Pompidou, Université René Descartes, Paris, France
| | - M.M. Brown
- Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, London, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Abe K, Abgrall N, Aihara H, Akiri T, Albert JB, Andreopoulos C, Aoki S, Ariga A, Ariga T, Assylbekov S, Autiero D, Barbi M, Barker GJ, Barr G, Bass M, Batkiewicz M, Bay F, Bentham SW, Berardi V, Berger BE, Berkman S, Bertram I, Beznosko D, Bhadra S, Blaszczyk FDM, Blondel A, Bojechko C, Boyd S, Brailsford D, Bravar A, Bronner C, Brook-Roberge DG, Buchanan N, Calland RG, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Christodoulou G, Clifton A, Coleman J, Coleman SJ, Collazuol G, Connolly K, Cremonesi L, Curioni A, Dabrowska A, Danko I, Das R, Davis S, Day M, de André JPAM, de Perio P, De Rosa G, Dealtry T, Dennis SR, Densham C, Di Lodovico F, Di Luise S, Dobson J, Drapier O, Duboyski T, Dufour F, Dumarchez J, Dytman S, Dziewiecki M, Dziomba M, Emery S, Ereditato A, Escudero L, Finch AJ, Frank E, Friend M, Fujii Y, Fukuda Y, Furmanski AP, Galymov V, Gaudin A, Giffin S, Giganti C, Gilje K, Golan T, Gomez-Cadenas JJ, Gonin M, Grant N, Gudin D, Guzowski P, Hadley DR, Haesler A, Haigh MD, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayato Y, Hearty C, Helmer RL, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Holeczek J, Horikawa S, Huang K, Ichikawa AK, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine TJ, Ishida T, Ishii T, Ives SJ, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Johnson RA, Jo JH, Jonsson P, Joo KK, Jung CK, Kaboth A, Kaji H, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Kearns E, Khabibullin M, Khanam F, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim JY, Kim J, Kim SB, Kirby B, Kisiel J, Kitching P, Kobayashi T, Kogan G, Kolaceke A, Konaka A, Kormos LL, Korzenev A, Koseki K, Koshio Y, Kowalik K, Kreslo I, Kropp W, Kubo H, Kudenko Y, Kumaratunga S, Kurjata R, Kutter T, Lagoda J, Laihem K, Laing A, Laveder M, Lawe M, Lee KP, Licciardi C, Lim IT, Lindner T, Lister C, Litchfield RP, Longhin A, Lopez GD, Ludovici L, Macaire M, Magaletti L, Mahn K, Malek M, Manly S, Marchionni A, Marino AD, Marteau J, Martin JF, Maruyama T, Marzec J, Masliah P, Mathie EL, Matveev V, Mavrokoridis K, Mazzucato E, McCauley N, McFarland KS, McGrew C, McLachlan T, Messina M, Metelko C, Mezzetto M, Mijakowski P, Miller CA, Minamino A, Mineev O, Mine S, Missert A, Miura M, Monfregola L, Moriyama S, Mueller TA, Murakami A, Murdoch M, Murphy S, Myslik J, Nagasaki T, Nakadaira T, Nakahata M, Nakai T, Nakajima K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Naples D, Nicholls TC, Nielsen C, Nishikawa K, Nishimura Y, O’Keeffe HM, Obayashi Y, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser SM, Otani M, Owen RA, Oyama Y, Pac MY, Palladino V, Paolone V, Payne D, Pearce GF, Perevozchikov O, Perkin JD, Pinzon Guerra ES, Plonski P, Poplawska E, Popov B, Posiadala M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff PN, Ravonel M, Rayner MAM, Reeves M, Reinherz-Aronis E, Retiere F, Robert A, Rodrigues PA, Rondio E, Roth S, Rubbia A, Ruterbories D, Sacco R, Sakashita K, Sánchez F, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Scully DI, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shibata M, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smith RJ, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Szeglowski T, Szeptycka M, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HA, Tanaka MM, Tanaka M, Taylor IJ, Terhorst D, Terri R, Thompson LF, Thorley A, Tobayama S, Toki W, Tomura T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Ueno K, Vacheret A, Vagins M, Vasseur G, Wachala T, Waldron AV, Walter CW, Wang J, Wark D, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Williamson Z, Wilson JR, Wilson RJ, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yen S, Yershov N, Yokoyama M, Yuan T, Zalewska A, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J. Measurement of the inclusiveνμcharged current cross section on carbon in the near detector of the T2K experiment. Int J Clin Exp Med 2013. [DOI: 10.1103/physrevd.87.092003] [Citation(s) in RCA: 83] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
42
|
Dupuis DR, Baxter C, Dobson J. Developmental Evaluation: Applying Complexity Concepts to Enhance Innovation and Use Patton, M. Q. (2011). New York: Guilford Press; vii-375. J Community Appl Soc Psychol 2013. [DOI: 10.1002/casp.2116] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
| | - Claire Baxter
- Department of Psychology; University of Guelph; Canada
| | | |
Collapse
|
43
|
Abstract
A five-year-old female boxer presented with a swelling in the area of the caudal mammary gland. The mass was surgically excised and histopathological examination revealed a poorly demarcated lesion, extending into mammary tissue and infiltrating the sinuses of adjacent lymph nodes. The diagnosis was lymphangiosarcoma. Full blood work, thoracic radiographs, abdominal and scar ultrasound were unremarkable, apart from possible inflammatory reactions in the latter and reactive/metastatic changes in inguinal lymph nodes. Doxorubicin treatment resulted in a 6-month recurrence free interval. At relapse, the dog was treated with metronomic chemotherapy using chlorambucil and meloxicam, which failed to adequately control the disease. Toceranib phosphate was introduced and resulted in almost complete regression of the mass, leaving just a skin plaque. To the authors' knowledge this is the first report describing the use of two novel therapeutic approaches to treat canine lymphangiosarcoma that resulted in a higher than previously described survival time.
Collapse
Affiliation(s)
- A Marcinowska
- Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES
| | | | | | | |
Collapse
|
44
|
Mehta P, Holder S, Fisher B, Vincent T, Nadesalingam K, Maciver H, Shingler W, Bakshi J, Hassan S, D'Cruz D, Chan A, Litwic AE, McCrae F, Seth R, McCrae F, Nandagudi A, Jury E, Isenberg D, Karjigi U, Paul A, Rees F, O'Dowd E, Kinnear W, Johnson S, Lanyon P, Bakshi J, Stevens R, Narayan N, Marguerie C, Robinson H, Ffolkes L, Worsnop F, Ostlere L, Kiely P, Dharmapalaiah C, Hassan N, Nandagudi A, Bharadwaj A, Skibinska M, Gendi N, Davies EJ, Akil M, Kilding R, Ramachandran Nair J, Walsh M, Farrar W, Thompson RN, Borukhson L, McFadyen C, Singh D, Rajagopal V, Chan AML, Wearn Koh L, Christie JD, Croot L, Gayed M, Disney B, Singhal S, Grindulis K, Reynolds TD, Conway K, Williams D, Quin J, Dean G, Churchill D, Walker-Bone KE, Goff I, Reynolds G, Grove M, Patel P, Lazarus MN, Roncaroli F, Gabriel C, Kinderlerer AR, Nikiphorou E, Hall FC, Bruce E, Gray L, Krutikov M, Wig S, Bruce I, D'Agostino MA, Wakefield R, Berner Hammer H, Vittecoq O, Galeazzi M, Balint P, Filippucci E, Moller I, Iagnocco A, Naredo E, Ostergaard M, Gaillez C, Kerselaers W, Van Holder K, Le Bars M, Stone MA, Williams F, Wolber L, Karppinen J, Maatta J, Thompson B, Atchia I, Lorenzi A, Raftery G, Platt P, Platt PN, Pratt A, Turmezei TD, Treece GM, Gee AH, Poole KE, Chandratre PN, Roddy E, Clarson L, Richardson J, Hider S, Mallen C, Lieberman A, Prouse PJ, Mahendran P, Samarawickrama A, Churchill D, Walker-Bone KE, Ottery FD, Yood R, Wolfson M, Ang A, Riches P, Thomson J, Nuki G, Humphreys J, Verstappen SM, Chipping J, Hyrich K, Marshall T, Symmons DP, Roy M, Kirwan JR, Marshall RW, Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Scott DL, Steer S, Ma MH, Dahanayake C, Scott IC, Kingsley G, Cope A, Scott DL, Dahanayake C, Ma MH, Scott IC, Kingsley GH, Cope A, Scott DL, Wernham A, Ward L, Carruthers D, Deeming A, Buckley C, Raza K, De Pablo P, Nikiphorou E, Carpenter L, Jayakumar K, Solymossy C, Dixey J, Young A, Singh A, Penn H, Ellerby N, Mattey DL, Packham J, Dawes P, Hider SL, Ng N, Humby F, Bombardieri M, Kelly S, Di Cicco M, Dadoun S, Hands R, Rocher V, Kidd B, Pyne D, Pitzalis C, Poore S, Hutchinson D, Low A, Lunt M, Mercer L, Galloway J, Davies R, Watson K, Dixon W, Symmons D, Hyrich K, Mercer L, Lunt M, Low A, Galloway J, Watson KD, Dixon WG, Symmons D, Hyrich KL, Low A, Lunt M, Mercer L, Bruce E, Dixon W, Hyrich K, Symmons D, Malik SP, Kelly C, Hamilton J, Heycock C, Saravanan V, Rynne M, Harris HE, Tweedie F, Skaparis Y, White M, Scott N, Samson K, Mercieca C, Clarke S, Warner AJ, Humphreys J, Lunt M, Marshall T, Symmons D, Verstappen S, Chan E, Kelly C, Woodhead FA, Nisar M, Arthanari S, Dawson J, Sathi N, Ahmad Y, Koduri G, Young A, Kelly C, Chan E, Ahmad Y, Woodhead FA, Nisar M, Arthanari S, Dawson J, Sathi N, Koduri G, Young A, Cumming J, Stannett P, Hull R, Metsios G, Stavropoulos Kalinoglou A, Veldhuijzen van Zanten JJ, Nightingale P, Koutedakis Y, Kitas GD, Nikiphorou E, Dixey J, Williams P, Kiely P, Walsh D, Carpenter L, Young A, Perry E, Kelly C, de-Soyza A, Moullaali T, Eggleton P, Hutchinson D, Veldhuijzen van Zanten JJ, Metsios G, Stavropoulos-Kalinoglou A, Sandoo A, Kitas GD, de Pablo P, Maggs F, Carruthers D, Faizal A, Pugh M, Jobanputra P, Kehoe O, Cartwright A, Askari A, El Haj A, Middleton J, Aynsley S, Hardy J, Veale D, Fearon U, Wilson G, Muthana M, Fossati G, Healy L, Nesbitt A, Becerra E, Leandro MJ, De La Torre I, Cambridge G, Nelson PN, Roden D, Shaw M, Davari Ejtehadi H, Nevill A, Freimanis G, Hooley P, Bowman S, Alavi A, Axford J, Veitch AM, Tugnet N, Rylance PB, Hawtree S, Muthana M, Aynsley S, Mark Wilkinson J, Wilson AG, Woon Kam N, Filter A, Buckley C, Pitzalis C, Bombardieri M, Croft AP, Naylor A, Zimmermann B, Hardie D, Desanti G, Jaurez M, Muller-Ladner U, Filer A, Neumann E, Buckley C, Movahedi M, Lunt M, Ray DW, Dixon WG, Burmester GR, Matucci-Cerinic M, Navarro-Blasco F, Kary S, Unnebrink K, Kupper H, Mukherjee S, Cornell P, Richards S, Rahmeh F, Thompson PW, Westlake SL, Javaid MK, Batra R, Chana J, Round G, Judge A, Taylor P, Patel S, Cooper C, Ravindran V, Bingham CO, Weinblatt ME, Mendelsohn A, Kim L, Mack M, Lu J, Baker D, Westhovens R, Hewitt J, Han C, Keystone EC, Fleischmann R, Smolen J, Emery P, Genovese M, Doyle M, Hsia EC, Hart JC, Lazarus MN, Kinderlerer AR, Harland D, Gibbons C, Pang H, Huertas C, Diamantopoulos A, Dejonckheere F, Clowse M, Wolf D, Stach C, Kosutic G, Williams S, Terpstra I, Mahadevan U, Smolen J, Emery P, Ferraccioli G, Samborski W, Berenbaum F, Davies O, Koetse W, Bennett B, Burkhardt H, Weinblatt ME, Fleischmann R, Davies O, Luijtens K, van der Heijde D, Mariette X, van Vollenhoven RF, Bykerk V, de Longueville M, Arendt C, Luijtens K, Cush J, Khan A, Maclaren Z, Dubash S, Chalam VC, Sheeran T, Price T, Baskar S, Mulherin D, Molloy C, Keay F, Heritage C, Douglas B, Fleischmann R, Weinblatt ME, Schiff MH, Khanna D, Furst DE, Maldonado MA, Li W, Sasso EH, Emerling D, Cavet G, Ford K, Mackenzie-Green B, Collins D, Price E, Williamson L, Golla J, Vagadia V, Morrison E, Tierney A, Wilson H, Hunter J, Ma MH, Scott DL, Reddy V, Moore S, Ehrenstein M, Benson C, Wray M, Cairns A, Wright G, Pendleton A, McHenry M, Taggart A, Bell A, Bosworth A, Cox M, Johnston G, Shah P, O'Brien A, Jones P, Sargeant I, Bukhari M, Nusslein H, Alten R, Galeazzi M, Lorenz HM, Boumpas D, Nurmohamed MT, Bensen W, Burmester GR, Peter HH, Rainer F, Pavelka K, Chartier M, Poncet C, Rauch C, Le Bars M, Lempp H, Hofmann D, Adu A, Congreve C, Dobson J, Rose D, Simpson C, Wykes T, Cope A, Scott DL, Ibrahim F, Schiff M, Alten R, Weinblatt ME, Nash P, Fleischmann R, Durez P, Kaine J, Delaet I, Kelly S, Maldonado M, Patel S, Genovese M, Jones G, Sebba A, Lepley D, Devenport J, Bernasconi C, Smart D, Mpofu C, Gomez-Reino JJ, Verma I, Kaur J, Syngle A, Krishan P, Vohra K, Kaur L, Garg N, Chhabara M, Gibson K, Woodburn J, Telfer S, Buckley F, Finckh A, Huizinga TW, Dejonckheere F, Jansen JP, Genovese M, Sebba A, Rubbert-Roth A, Scali JJ, Alten R, Kremer JM, Pitts L, Vernon E, van Vollenhoven RF, Sharif MI, Das S, Emery P, Maciver H, Shingler W, Helliwell P, Sokoll K, Vital EM. Case Reports * 1. A Late Presentation of Loeys-Dietz Syndrome: Beware of TGF Receptor Mutations in Benign Joint Hypermobility. Rheumatology (Oxford) 2013. [DOI: 10.1093/rheumatology/ket197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
45
|
Prieto-Merino D, Dobson J, Gupta AK, Chang CL, Sever PS, Dahlöf B, Wedel H, Pocock S, Poulter N. ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data. J Hum Hypertens 2013; 27:492-6. [DOI: 10.1038/jhh.2013.3] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2012] [Revised: 12/17/2012] [Accepted: 12/28/2012] [Indexed: 11/09/2022]
|
46
|
Abe K, Abgrall N, Aihara H, Akiri T, Albert JB, Andreopoulos C, Aoki S, Ariga A, Ariga T, Assylbekov S, Autiero D, Barbi M, Barker GJ, Barr G, Bass M, Batkiewicz M, Bay F, Bentham SW, Berardi V, Berger BE, Berkman S, Bertram I, Beznosko D, Bhadra S, Blaszczyk FDM, Blondel A, Bojechko C, Boyd S, Bravar A, Bronner C, Brook-Roberge DG, Buchanan N, Calland RG, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Christodoulou G, Clifton A, Coleman J, Coleman SJ, Collazuol G, Connolly K, Curioni A, Dabrowska A, Danko I, Das R, Davis S, Day M, de André JPAM, de Perio P, De Rosa G, Dealtry T, Densham C, Di Lodovico F, Di Luise S, Dobson J, Duboyski T, Dufour F, Dumarchez J, Dytman S, Dziewiecki M, Dziomba M, Emery S, Ereditato A, Escudero L, Esposito LS, Finch AJ, Frank E, Friend M, Fujii Y, Fukuda Y, Galymov V, Gaudin A, Giffin S, Giganti C, Gilje K, Golan T, Gomez-Cadenas JJ, Gonin M, Grant N, Gudin D, Guzowski P, Hadley DR, Haesler A, Haigh MD, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayato Y, Hearty C, Helmer RL, Hignight J, Hillairet A, Himmel A, Hiraki T, Holeczek J, Horikawa S, Huang K, Hyndman A, Ichikawa AK, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Ishida T, Ishii T, Ives SJ, Iyogi K, Izmaylov A, Jamieson B, Johnson RA, Jo JH, Jonsson P, Joo KK, Jover-Manas GV, Jung CK, Kaji H, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Kearns E, Khabibullin M, Khanam F, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim JY, Kim J, Kim SB, Kirby B, Kisiel J, Kitching P, Kobayashi T, Kogan G, Konaka A, Kormos LL, Korzenev A, Koseki K, Koshio Y, Kowalik K, Kreslo I, Kropp W, Kubo H, Kudenko Y, Kumaratunga S, Kurjata R, Kutter T, Lagoda J, Laihem K, Laing A, Laveder M, Lawe M, Lee KP, Licciardi C, Lim IT, Lindner T, Lister C, Litchfield RP, Longhin A, Lopez GD, Ludovici L, Macaire M, Magaletti L, Mahn K, Malek M, Manly S, Marchionni A, Marino AD, Marteau J, Martin JF, Maruyama T, Marzec J, Masliah P, Mathie EL, Matsumura C, Matsuoka K, Matveev V, Mavrokoridis K, Mazzucato E, McCauley N, McFarland KS, McGrew C, McLachlan T, Messina M, Metelko C, Mezzetto M, Mijakowski P, Miller CA, Minamino A, Mineev O, Mine S, Missert A, Miura M, Monfregola L, Moriyama S, Mueller TA, Murakami A, Murdoch M, Murphy S, Myslik J, Nagasaki T, Nakadaira T, Nakahata M, Nakai T, Nakajima K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Naples D, Nicholls TC, Nielsen C, Nishikawa K, Nishimura Y, O’Keeffe HM, Obayashi Y, Ohta R, Okumura K, Oryszczak W, Oser SM, Otani M, Owen RA, Oyama Y, Pac MY, Palladino V, Paolone V, Payne D, Pearce GF, Perevozchikov O, Perkin JD, Pinzon Guerra ES, Plonski P, Poplawska E, Popov B, Posiadala M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff PN, Ravonel M, Rayner MA, Reeves M, Reinherz-Aronis E, Retiere F, Rodrigues PA, Rondio E, Rossi B, Roth S, Rubbia A, Ruterbories D, Sacco R, Sakashita K, Sánchez F, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Scully DI, Seiya Y, Sekiguchi T, Sekiya H, Shibata M, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smith RJ, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Sulej R, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Szeglowski T, Szeptycka M, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HA, Tanaka M, Tanaka MM, Taylor IJ, Terhorst D, Terri R, Thompson LF, Thorley A, Tobayama S, Toki W, Tomura T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Ueno K, Vacheret A, Vagins M, Vasseur G, Wachala T, Waldron AV, Walter CW, Wang J, Wark D, Wascko MO, Weber A, Wendell R, Wikström G, Wilkes RJ, Wilking MJ, Wilkinson C, Williamson Z, Wilson JR, Wilson RJ, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yuan T, Zalewska A, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J. T2K neutrino flux prediction. Int J Clin Exp Med 2013. [DOI: 10.1103/physrevd.87.012001 10.1103/physrevd.87.019902] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
47
|
Warland J, Amores-Fuster I, Newbury W, Brearley M, Dobson J. The utility of staging in canine mast cell tumours. Vet Comp Oncol 2012; 12:287-98. [DOI: 10.1111/vco.12012] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2012] [Revised: 09/18/2012] [Accepted: 10/30/2012] [Indexed: 12/20/2022]
Affiliation(s)
- J. Warland
- Department of Veterinary Medicine; Queen's Veterinary School Hospital, University of Cambridge; Cambridge UK
| | - I. Amores-Fuster
- School of Veterinary Science, Small Animal Teaching Hospital; University of Liverpool; Liverpool UK
| | | | - M. Brearley
- Department of Veterinary Medicine; Queen's Veterinary School Hospital, University of Cambridge; Cambridge UK
| | - J. Dobson
- Department of Veterinary Medicine; Queen's Veterinary School Hospital, University of Cambridge; Cambridge UK
| |
Collapse
|
48
|
Van den Steen N, Berlato D, Polton G, Dobson J, Stewart J, Maglennon G, Hayes AM, Murphy S. Rectal lymphoma in 11 dogs - a retrospective study. J Small Anim Pract 2012; 53:586-91. [DOI: 10.1111/j.1748-5827.2012.01258.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- N. Van den Steen
- Centre for Small Animal Studies; Animal Health Trust; Lanwades Park, Bury Road; Kentford; Newmarket; Suffolk CB8 7UU
| | | | | | | | | | | | | | - S. Murphy
- Centre for Small Animal Studies; Animal Health Trust; Lanwades Park, Bury Road; Kentford; Newmarket; Suffolk CB8 7UU
| |
Collapse
|
49
|
Fouriki A, Clements M, Farrow N, Dobson J. Efficient transfection of MG-63 osteoblasts using magnetic nanoparticles and oscillating magnetic fields. J Tissue Eng Regen Med 2012; 8:169-75. [DOI: 10.1002/term.1508] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2011] [Revised: 01/24/2012] [Accepted: 01/31/2012] [Indexed: 11/05/2022]
Affiliation(s)
- A. Fouriki
- Institute for Science & Technology in Medicine; Keele University; Thornburrow Drive Hartshill Stoke-on-Trent UK
| | - M.A. Clements
- Waggoner Center for Alcohol and Addiction Research, College of Natural Sciences; University of Texas at Austin; Austin Texas USA
| | - N. Farrow
- NanoTherics Limited; Guy Hilton Research Centre; Thornburrow Drive Hartshill Stoke-on-Trent UK
| | - J. Dobson
- Institute for Science & Technology in Medicine; Keele University; Thornburrow Drive Hartshill Stoke-on-Trent UK
- J. Crayton Pruitt Family Department of Biomedical Engineering and Department of Materials Science & Engineering; University of Florida; Gainesville Florida USA
| |
Collapse
|
50
|
Demetriou JL, Brearley MJ, Constantino-Casas F, Addington C, Dobson J. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy. J Small Anim Pract 2012; 53:174-81. [DOI: 10.1111/j.1748-5827.2011.01186.x] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|